https://novapharmanews.com/us/news/adial-pharmaceuticals-cdo-adds-equity-after-azora-merger 2026-07-01T19:58:13.046Z weekly 0.7 https://novapharmanews.com/eu/news/eu-pharma-package-exclusivity-timelines-what-innovators-can-do-now 2026-07-01T05:25:31.935Z weekly 0.7 https://novapharmanews.com/us/news/biotechs-coming-of-age-ai-capital-efficiency-china 2026-07-01T13:39:18.534Z weekly 0.7 https://novapharmanews.com/us/news/edgewise-therapeutics-edg-7500-phase-2-cirrus-hcm-test 2026-07-01T13:39:17.811Z weekly 0.7 https://novapharmanews.com/us/news/celiac-disease-new-era-therapeutic-innovation 2026-07-01T13:39:22.985Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-otc-rextovy-broadening-naloxone-access-opioid-overdose 2026-07-01T13:39:17.833Z weekly 0.7 https://novapharmanews.com/us/news/neumora-navacaprant-fails-phase-3-engene-cuts-50-percent-of-staff 2026-07-01T15:02:25.389Z weekly 0.7 https://novapharmanews.com/us/news/global-hematology-trials-patient-centered-regionally-relevant 2026-07-01T13:39:18.870Z weekly 0.7 https://novapharmanews.com/us/news/lilly-early-jak-data-myelofibrosis-competes-with-jakafi 2026-07-01T17:59:13.751Z weekly 0.7 https://novapharmanews.com/us/news/fda-authorizes-emergency-pet-treatment-new-world-screwworm 2026-06-30T20:12:06.051Z weekly 0.7 https://novapharmanews.com/us/news/fda-guidance-sharing-potential-nda-patent-information 2026-07-01T03:17:09.543Z weekly 0.7 https://novapharmanews.com/us/news/hillhurst-bio-doses-first-subject-phase-2a-hbi-002-parkinsons-trial 2026-07-01T06:25:55.531Z weekly 0.7 https://novapharmanews.com/us/news/fda-expands-tzield-pediatric-stage-3-type-1-diabetes 2026-07-01T17:53:57.425Z weekly 0.7 https://novapharmanews.com/eu/news/ema-board-backs-ebola-response-flags-2025-annual-report-june-2026-meeting 2026-07-01T20:05:28.147Z weekly 0.7 https://novapharmanews.com/us/news/medicare-price-rule-keytruda-opdivo-subcutaneous-launches 2026-07-01T16:12:37.653Z weekly 0.7 https://novapharmanews.com/eu/news/ema-tightens-liver-safety-checks-tavneos-avacopan 2026-07-01T20:13:39.635Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-capivasertib-pten-deficient-prostate-cancer 2026-07-01T20:14:46.666Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-belzutifan-plus-pembrolizumab-adjuvant-rcc 2026-07-01T17:36:29.255Z weekly 0.7 https://novapharmanews.com/apac/news/piyush-goyal-invites-global-pharma-firms-to-partner-with-india 2026-06-30T20:36:31.848Z weekly 0.7 https://novapharmanews.com/us/news/prescription-drug-freight-fraud-june-2026-report 2026-07-01T13:15:52.801Z weekly 0.7 https://novapharmanews.com/us/news/planning-a-successful-pivot-from-lab-to-clinic-practical-career-map 2026-06-30T17:01:18.972Z weekly 0.7 https://novapharmanews.com/eu/news/fda-approves-capivasertib-abiraterone-prednisone-pten-deficient-mhspc 2026-07-01T17:27:31.899Z weekly 0.7 https://novapharmanews.com/eu/news/china-big-pharma-essential-rd-partner 2026-07-01T05:14:45.959Z weekly 0.7 https://novapharmanews.com/us/news/hfma-conference-affordability-friction-high-hospital-costs 2026-07-01T16:50:07.414Z weekly 0.7 https://novapharmanews.com/us/news/fda-draft-guidance-payor-communications-rules 2026-07-01T09:44:48.903Z weekly 0.7 https://novapharmanews.com/eu/news/mhra-targets-medicine-safety-with-new-ai-sandbox 2026-07-01T17:17:32.008Z weekly 0.7 https://novapharmanews.com/eu/news/biocryst-new-orladeyo-data-real-world-evidence-hae 2026-07-01T10:44:57.000Z weekly 0.7 https://novapharmanews.com/eu/news/ema-researchers-map-ai-research-priorities-across-the-medicines-lifecycle 2026-06-29T23:28:20.782Z weekly 0.7 https://novapharmanews.com/us/news/alembic-tentative-fda-approval-generic-larotrectinib-capsules 2026-07-01T09:45:34.064Z weekly 0.7 https://novapharmanews.com/eu/news/truqap-us-approval-pten-deficient-metastatic-prostate-cancer 2026-07-01T17:49:18.856Z weekly 0.7 https://novapharmanews.com/us/news/fda-clears-first-otc-cgm-for-children-dexcom-stelo 2026-07-01T19:45:01.145Z weekly 0.7 https://novapharmanews.com/us/news/fda-priority-review-belzutifan-pembrolizumab-adjuvant-renal-cell-carcinoma 2026-06-30T20:12:08.395Z weekly 0.7 https://novapharmanews.com/us/news/chile-warning-labels-on-food-new-evidence-efficacy-obesity-risk 2026-07-01T07:05:36.843Z weekly 0.7 https://novapharmanews.com/eu/news/duty-of-care-oncology-conferences-planetary-health-research 2026-06-22T15:00:25.013Z weekly 0.7 https://novapharmanews.com/us/news/socioeconomic-status-shapes-childrens-brain-development-study-finds 2026-07-01T13:39:15.269Z weekly 0.7 https://novapharmanews.com/eu/news/synthetic-real-world-data-oncology-trial-decision-making 2026-06-30T19:24:21.557Z weekly 0.7 https://novapharmanews.com/us/news/fda-bemotrizinol-sunscreen-regulatory-update 2026-06-30T08:40:43.214Z weekly 0.7 https://novapharmanews.com/us/news/biotech-coming-of-age-market-analysis 2026-06-30T19:04:20.832Z weekly 0.7 https://novapharmanews.com/eu/news/ema-approved-104-human-medicines-in-2025-what-changed 2026-06-30T23:06:44.325Z weekly 0.7 https://novapharmanews.com/eu/news/ema-post-authorisation-guidance-evidence-gaps-10-years 2026-07-01T10:00:56.505Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-vepdegestrant-veppanu-esr1-mutated-breast-cancer 2026-07-01T16:53:48.460Z weekly 0.7 https://novapharmanews.com/us/news/cdc-data-alcohol-use-during-pregnancy-rising-again 2026-07-01T09:47:10.207Z weekly 0.7 https://novapharmanews.com/us/news/sensorion-pivots-to-sens-601-after-regenerons-otof-hearing-loss-advance 2026-07-01T19:06:22.549Z weekly 0.7 https://novapharmanews.com/us/news/takeda-tyk2-drug-tops-bristol-myers-sotyktu-psoriasis-head-to-head-test 2026-07-01T20:16:37.446Z weekly 0.7 https://novapharmanews.com/us/news/fda-guidance-human-factors-information-marketing-submissions 2026-07-01T02:00:24.816Z weekly 0.7 https://novapharmanews.com/us/news/fda-authorizes-generic-nitenpyram-new-world-screwworm-pets 2026-07-01T17:59:58.322Z weekly 0.7 https://novapharmanews.com/us/news/sls-stock-jumps-biotech-momentum-sellas-gains-2510-percent 2026-06-30T22:45:18.268Z weekly 0.7 https://novapharmanews.com/us/news/hhs-responds-coolly-to-alcohol-risk-paper-amid-cancer-warning-debate 2026-07-01T02:24:14.059Z weekly 0.7 https://novapharmanews.com/apac/news/blood-pressure-ischemic-stroke-risk-dementia-nationwide-cohort 2026-07-01T20:23:14.150Z weekly 0.7 https://novapharmanews.com/us/news/sepsis-ai-algorithms-need-real-time-data-not-hindsight 2026-06-30T01:57:36.343Z weekly 0.7 https://novapharmanews.com/eu/news/ema-approves-tx01-pip-unlocking-puma-pathway-theranexus-exeltis 2026-07-01T13:24:21.816Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-first-interchangeable-biosimilars-simponi-simponi-aria 2026-07-01T18:32:40.915Z weekly 0.7 https://novapharmanews.com/us/news/astrazeneca-obesity-push-ultrasound-genetic-medicine-125m 2026-07-01T19:16:58.133Z weekly 0.7 https://novapharmanews.com/eu/news/chmp-backs-nerandomilast-for-ipf-and-ppf-in-eu 2026-07-01T17:18:12.940Z weekly 0.7 https://novapharmanews.com/us/news/fda-drug-approval-what-approval-means-for-pharma-marketing-bd 2026-06-30T21:42:17.951Z weekly 0.7 https://novapharmanews.com/apac/news/pmda-approves-enhertu-for-her2-low-breast-cancer-in-japan 2026-07-01T14:01:45.091Z weekly 0.7 https://novapharmanews.com/us/news/fda-salmonella-moringa-leaf-powder-recall-january-2026 2026-07-01T15:58:55.547Z weekly 0.7 https://novapharmanews.com/eu/news/krx-ir-reference-s896010510626060808350-scd-ndr-eng-jun-2026 2026-07-01T05:33:57.448Z weekly 0.7 https://novapharmanews.com/us/news/nektar-therapeutics-pipeline-update-rezpeg-amphotericin-b-uk-site-changes 2026-06-29T23:20:55.883Z weekly 0.7 https://novapharmanews.com/us/news/vanda-tradipitant-update-fda-re-review-dec-5-2025 2026-07-01T19:35:21.312Z weekly 0.7 https://novapharmanews.com/us/news/sanofi-pipeline-pdf-dupixent-lantus-2026-catalysts 2026-07-01T19:20:52.473Z weekly 0.7 https://novapharmanews.com/us/news/cardiff-oncology-pipeline-update-onvansertib-trials-fda-meeting-catalysts 2026-07-01T13:37:07.524Z weekly 0.7 https://novapharmanews.com/us/news/alnylam-pipeline-update-amvuttra-catalysts-outlook-profitability 2026-07-01T19:09:16.750Z weekly 0.7 https://novapharmanews.com/us/news/neurocrine-biosciences-pipeline-update-catalyst-watch 2026-07-01T15:17:16.222Z weekly 0.7 https://novapharmanews.com/us/news/arcus-biosciences-pipeline-catalyst-update-casdatifan-quemliclustat-domvanalimab 2026-07-01T19:23:26.214Z weekly 0.7 https://novapharmanews.com/us/news/syndax-pipeline-update-revuforj-niktimvo-catalysts 2026-07-01T13:30:35.607Z weekly 0.7 https://novapharmanews.com/us/news/tillomed-laboratories-pipeline-catalyst-update 2026-07-01T13:39:21.821Z weekly 0.7 https://novapharmanews.com/us/news/2m-gene-therapy-cures-financing-model 2026-06-30T20:12:10.607Z weekly 0.7 https://novapharmanews.com/apac/news/tga-australia-drug-approval-pharmaceutical 2026-06-28T20:11:32.805Z weekly 0.7 https://novapharmanews.com/us/news/precision-under-pressure-logistics-facts-nuclear-medicine-scalability 2026-06-30T17:36:19.288Z weekly 0.7 https://novapharmanews.com/us/news/innovation-alone-no-longer-enough-biopharma 2026-07-01T05:50:21.308Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-lumasiran-acute-hepatic-porphyria-2026 2026-07-01T14:59:58.958Z weekly 0.7 https://novapharmanews.com/eu/news/eu-secures-emergency-favipiravir-deliveries-hantavirus-response 2026-07-01T06:24:23.976Z weekly 0.7 https://novapharmanews.com/eu/news/eye-drugs-list-sodium-hyaluronate-tafluprost-tobramycin-uses 2026-07-01T20:13:05.000Z weekly 0.7 https://novapharmanews.com/apac/news/areas-with-risk-of-dengue-cdc-map-criteria-global-reach 2026-07-01T19:02:47.401Z weekly 0.7 https://novapharmanews.com/us/news/breast-cancer-statistics-worldwide-what-the-data-shows 2026-07-01T05:27:53.663Z weekly 0.7 https://novapharmanews.com/us/news/manufacturing-pipeline-approvals-evidence-confirms 2026-06-30T23:36:59.375Z weekly 0.7 https://novapharmanews.com/us/news/glp-1-usage-statistics-data-shows 2026-06-30T23:48:24.775Z weekly 0.7 https://novapharmanews.com/us/news/novo-nordisk-supply-wegovy-stabilizes-new-manufacturing-capacity 2026-07-01T11:28:53.385Z weekly 0.7 https://novapharmanews.com/us/news/biontech-first-patient-phase-1-pancreatic-cancer-mrna-vaccine-trial 2026-07-01T19:52:28.912Z weekly 0.7 https://novapharmanews.com/us/news/maritide-phase-2-obesity-data-20-percent-weight-loss-one-year 2026-07-01T12:32:00.513Z weekly 0.7 https://novapharmanews.com/us/news/gsk-blenrep-returns-us-market-fda-approves-resubmission 2026-07-01T18:08:03.735Z weekly 0.7 https://novapharmanews.com/us/news/moderna-mrna-1083-phase-3-flu-covid-immune-response 2026-07-01T18:25:15.512Z weekly 0.7 https://novapharmanews.com/us/news/danuglipron-phase-3-pfizer-phase-2b-obesity-trial 2026-07-01T17:15:50.106Z weekly 0.7 https://novapharmanews.com/us/news/biogen-eisai-expand-leqembi-access-subcutaneous-maintenance-dosing 2026-07-01T12:17:30.269Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-vyloy-her2-negative-gastric-gej-cancer 2026-07-01T19:18:12.372Z weekly 0.7 https://novapharmanews.com/us/news/novo-nordisk-supply-of-wegovy-stabilizes-as-fda-shortage-ends 2026-07-01T11:28:53.386Z weekly 0.7 https://novapharmanews.com/us/news/jj-reports-positive-phase-3-tremfya-data-ulcerative-colitis 2026-06-30T15:43:15.084Z weekly 0.7 https://novapharmanews.com/us/news/sanofi-completes-inhibrx-acquisition-for-1-7b 2026-07-01T17:09:18.603Z weekly 0.7 https://novapharmanews.com/us/news/mari-tide-phase-2-amgen-reports-up-to-20-percent-weight-loss-at-one-year 2026-07-01T15:55:02.237Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-dupixent-for-copd-eosinophilic-phenotype 2026-07-01T17:04:32.254Z weekly 0.7 https://novapharmanews.com/us/news/gsk-blenrep-fda-approval-relapsed-multiple-myeloma 2026-07-01T19:40:06.037Z weekly 0.7 https://novapharmanews.com/us/news/merck-harpoon-therapeutics-acquisition-oncology-pipeline 2026-07-01T15:38:21.633Z weekly 0.7 https://novapharmanews.com/us/news/pfizer-danuglipron-phase-2b-obesity-endpoint 2026-07-01T07:41:33.718Z weekly 0.7 https://novapharmanews.com/us/news/roche-positive-phase-3-trontinemab-alzheimers-disease 2026-07-01T11:11:07.421Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-keytruda-adjuvant-nsclc-merck 2026-07-01T06:07:42.366Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-mercks-keytruda-adjuvant-nsclc-treatment 2026-07-01T13:01:57.005Z weekly 0.7 https://novapharmanews.com/us/news/eli-lilly-donanemab-wins-fda-approval-early-alzheimers-disease 2026-07-01T16:55:52.960Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-keytruda-adjuvant-nsclc-merck-catalyst 2026-06-30T20:12:18.114Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-keytruda-adjuvant-nsclc-early-stage-lung-cancer 2026-07-01T16:49:28.906Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-keytruda-adjuvant-nsclc-merck-investor-watch 2026-07-01T18:23:53.728Z weekly 0.7 https://novapharmanews.com/us/news/novo-nordisk-cagrisema-phase-3-obesity-results-catalyst 2026-07-01T16:01:28.818Z weekly 0.7 https://novapharmanews.com/apac/news/fosun-pharma-aribio-option-agreement 2026-07-01T02:45:19.578Z weekly 0.7 https://novapharmanews.com/us/news/triple-hormone-receptor-agonist-retatrutide-obesity-phase-3-results 2026-07-01T18:30:35.295Z weekly 0.7 https://novapharmanews.com/us/news/fda-industry-friendly-gene-therapy-guidance-bd 2026-07-01T14:06:14.378Z weekly 0.7 https://novapharmanews.com/us/news/johnson-and-johnson-asco-2026-data-adds-depth-to-jnj-valuation-story 2026-07-01T00:14:58.414Z weekly 0.7 https://novapharmanews.com/us/news/pfizer-berobenatide-obesity-drug-vesper-3-data 2026-06-30T20:59:21.429Z weekly 0.7 https://novapharmanews.com/us/news/puma-biotechnology-inducement-awards-nasdaq-5635c4-june-2026 2026-06-30T18:09:04.377Z weekly 0.7 https://novapharmanews.com/eu/news/world-lightproof-bottle-opaque-liners-market-pharma-growth-2035 2026-07-01T04:47:53.830Z weekly 0.7 https://novapharmanews.com/apac/news/pmda-regulatory-updates-orphan-drug-portal-asean-symposium 2026-06-30T09:41:38.459Z weekly 0.7 https://novapharmanews.com/eu/news/emea-2026-life-sciences-industry-cluster-report-market-analysis 2026-07-01T19:48:24.245Z weekly 0.7 https://novapharmanews.com/us/news/facet-life-sciences-appoints-frank-closurdo-vp-commercial-services 2026-07-01T10:01:02.117Z weekly 0.7 https://novapharmanews.com/us/news/pfizer-berobenatide-monthly-obesity-drug-phase-2b-data 2026-07-01T18:01:36.108Z weekly 0.7 https://novapharmanews.com/us/news/listeria-outbreak-soft-cheese-fda-investigation 2026-07-01T16:00:08.611Z weekly 0.7 https://novapharmanews.com/us/news/cdc-ebola-outbreak-central-africa-20000-cases-2026 2026-06-29T16:43:15.457Z weekly 0.7 https://novapharmanews.com/apac/news/nmpa-china-fda-drug-approval-2026-pathways-timelines-impact 2026-07-01T16:28:36.739Z weekly 0.7 https://novapharmanews.com/eu/news/maersk-europe-market-update-june-2026-pharma-supply-chains 2026-07-01T20:22:49.430Z weekly 0.7 https://novapharmanews.com/eu/news/regulatory-round-up-2-february-2026 2026-06-30T23:05:28.754Z weekly 0.7 https://novapharmanews.com/us/news/fda-issues-june-2026-guidance-gene-therapy-payor-comms-cmc-flexibilities 2026-07-01T18:17:37.417Z weekly 0.7 https://novapharmanews.com/us/news/friday-five-asco-takeaways-ada-china-deals-clinical-trials 2026-07-01T18:41:34.861Z weekly 0.7 https://novapharmanews.com/us/news/pharmalittle-roche-blackmail-skinny-labels-supreme-court 2026-07-01T16:25:31.343Z weekly 0.7 https://novapharmanews.com/us/news/ebola-2026-us-response-travel-restrictions-debate 2026-07-01T00:38:54.383Z weekly 0.7 https://novapharmanews.com/us/news/senior-nih-official-pushes-maha-strategy-to-skeptical-ada-audience 2026-06-30T03:19:31.933Z weekly 0.7 https://novapharmanews.com/us/news/newer-glp-1s-pushback-research-cuts-protest 2026-06-29T10:07:18.548Z weekly 0.7 https://novapharmanews.com/us/news/abivax-colitis-drug-hits-goal-cancer-cases-rattle-investors 2026-06-30T15:21:47.857Z weekly 0.7 https://novapharmanews.com/us/news/supreme-court-sides-with-generic-drug-maker-icosapent-ethyl 2026-06-27T07:44:47.846Z weekly 0.7 https://novapharmanews.com/eu/news/baker-company-benelux-joins-europabio-cell-culture-lab-safety 2026-07-01T17:34:10.136Z weekly 0.7 https://novapharmanews.com/us/news/rx-rundown-pfizer-hikma-newlimit-drug-approvals-catalyst-tracker 2026-06-30T17:33:59.846Z weekly 0.7 https://novapharmanews.com/us/news/mira-pharmaceuticals-global-rights-mira-55-skny-1 2026-07-01T17:27:58.291Z weekly 0.7 https://novapharmanews.com/us/news/4-biotech-stocks-investors-should-watch-in-2026-market-analysis 2026-06-30T09:44:28.040Z weekly 0.7 https://novapharmanews.com/us/news/alabama-board-medical-examiners-warning-non-fda-approved-peptides 2026-06-30T17:05:12.427Z weekly 0.7 https://novapharmanews.com/us/news/vertex-fda-accepts-bla-povetacicept-iga-nephropathy-accelerated-approval 2026-07-01T16:03:37.815Z weekly 0.7 https://novapharmanews.com/us/news/aurobindo-pharma-oai-classification-drug-approvals 2026-07-01T13:37:18.929Z weekly 0.7 https://novapharmanews.com/us/news/lee-tuberville-introduce-protections-for-homeopathic-medicine-fda-approval-framework 2026-06-30T07:10:46.385Z weekly 0.7 https://novapharmanews.com/us/news/daraxonrasib-pancreatic-cancer-survival-2026 2026-07-01T13:56:57.835Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-ensitrelvir-xocova-first-oral-covid-19-post-exposure-prophylaxis 2026-07-01T20:05:08.354Z weekly 0.7 https://novapharmanews.com/us/news/generic-drugmakers-skinny-label-victory-hikma-amarin 2026-07-01T00:46:41.480Z weekly 0.7 https://novapharmanews.com/us/news/texas-ag-investigating-energy-drinks-pharma-implications 2026-06-29T21:03:38.511Z weekly 0.7 https://novapharmanews.com/eu/news/myasthenia-gravis-clinical-trial-pipeline-expands-25-companies-delveinsight 2026-07-01T12:10:03.258Z weekly 0.7 https://novapharmanews.com/eu/news/mfn-drug-pricing-reshapes-international-life-sciences-licensing-deals 2026-07-01T12:31:06.128Z weekly 0.7 https://novapharmanews.com/eu/news/india-oman-cepa-fast-tracks-drug-approvals-cuts-export-barriers 2026-07-01T00:51:45.933Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-companion-diagnostic-inavolisib-hr-her2-pik3ca-mutated-breast-cancer 2026-07-01T15:59:34.653Z weekly 0.7 https://novapharmanews.com/us/news/peptide-reclassification-rfk-jr-fda-announcement-pharmacist-take 2026-06-30T23:27:46.626Z weekly 0.7 https://novapharmanews.com/apac/news/vietnam-india-middle-power-diplomacy-pharma-market-analysis 2026-07-01T10:43:40.609Z weekly 0.7 https://novapharmanews.com/us/news/scientists-uncover-new-hiding-spot-hiv-bone-marrow 2026-06-30T00:29:46.483Z weekly 0.7 https://novapharmanews.com/us/news/trump-administration-strips-job-protections-nih-officials-pharma-impact 2026-06-30T22:30:32.179Z weekly 0.7 https://novapharmanews.com/apac/news/nmpa-drug-approvals-2025-record-first-global-approvals 2026-07-01T15:48:19.340Z weekly 0.7 https://novapharmanews.com/eu/news/ema-ama-african-regulators-ebola-clinical-trials-2026 2026-07-01T19:27:35.205Z weekly 0.7 https://novapharmanews.com/eu/news/chmp-negative-stance-acadia-rett-syndrome-drug 2026-07-01T19:18:30.583Z weekly 0.7 https://novapharmanews.com/eu/news/chmp-may-2026-output-shift-european-drug-development 2026-07-01T18:11:35.652Z weekly 0.7 https://novapharmanews.com/eu/news/eu-commission-advances-critical-medicines-act 2026-07-01T18:03:29.763Z weekly 0.7 https://novapharmanews.com/eu/news/hayes-esmo-breast-cancer-award-2026 2026-07-01T17:33:25.989Z weekly 0.7 https://novapharmanews.com/us/news/fierce-biotech-week-2026-recap 2026-07-01T17:31:07.579Z weekly 0.7 https://novapharmanews.com/us/news/astrazeneca-daiichi-drug-approval-breast-cancer 2026-07-01T15:54:54.150Z weekly 0.7 https://novapharmanews.com/eu/news/esmo-asia-nadia-harbeck-oncology-advances 2026-07-01T12:56:41.477Z weekly 0.7 https://novapharmanews.com/eu/news/who-europe-access-novel-medicines 2026-07-01T11:33:38.675Z weekly 0.7 https://novapharmanews.com/us/news/pharma-in-focus-regulatory-updates 2026-07-01T09:27:04.714Z weekly 0.7 https://novapharmanews.com/apac/news/decade-ai-medical-device-regulation-2015-2025 2026-07-01T06:07:50.219Z weekly 0.7 https://novapharmanews.com/apac/news/smarter-medical-devices-ecosystem-india-regulatory-updates 2026-07-01T06:07:49.798Z weekly 0.7 https://novapharmanews.com/us/news/fda-flashback-breast-cancer-april-2026 2026-06-30T20:15:47.238Z weekly 0.7 https://novapharmanews.com/eu/news/cancer-therapy-ost-her2-2026-ema-call 2026-06-30T19:00:39.991Z weekly 0.7 https://novapharmanews.com/apac/news/cell-gene-therapy-approvals-china-regulatory-updates 2026-06-30T17:34:41.236Z weekly 0.7 https://novapharmanews.com/eu/news/owkin-astrazeneca-ai-collaboration-drug-research 2026-06-27T12:38:27.576Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-first-oral-covid-19-pep-drug-xocova 2026-07-01T19:22:13.886Z weekly 0.7 https://novapharmanews.com/us/news/legend-biotech-in-vivo-car-t-lymphoma-data-surge 2026-07-01T14:02:16.132Z weekly 0.7 https://novapharmanews.com/us/news/halomd-lawsuit-update-highmark-health-no-surprises-act 2026-07-01T01:59:33.057Z weekly 0.7 https://novapharmanews.com/apac/news/regulatory-round-up-drug-approvals-18-may-2026 2026-07-01T15:47:48.454Z weekly 0.7 https://novapharmanews.com/eu/news/us-europe-biosimilar-approvals-2026 2026-07-01T07:03:17.792Z weekly 0.7 https://novapharmanews.com/eu/news/key-cancer-drugs-esmo-2025 2026-06-29T20:13:10.563Z weekly 0.7 https://novapharmanews.com/us/news/stat-trump-s-medicaid-work-requirements-have-an-unwelcome-surprise-for-some-states-and-patients 2026-07-01T19:40:18.528Z weekly 0.7 https://novapharmanews.com/us/news/military-eating-disorders-prevalence-impact 2026-07-01T01:30:42.395Z weekly 0.7 https://novapharmanews.com/eu/news/european-navenibart-deal-biocryst-analysis 2026-07-01T07:37:32.020Z weekly 0.7 https://novapharmanews.com/apac/news/risen-pharma-phase-2-trial-rp902-alzheimers 2026-07-01T09:30:34.442Z weekly 0.7 https://novapharmanews.com/us/news/fda-blueprint-regulatory-risk-animal-testing-alternatives 2026-07-01T10:08:50.976Z weekly 0.7 https://novapharmanews.com/apac/news/regulatory-updates-optical-coherence-tomography-pharma 2026-06-28T18:23:37.183Z weekly 0.7 https://novapharmanews.com/us/news/china-drug-development-oncology-us 2026-06-30T15:20:25.914Z weekly 0.7 https://novapharmanews.com/eu/news/horizon-scanning-ema-regulatory-updates 2026-06-30T20:38:09.562Z weekly 0.7 https://novapharmanews.com/apac/news/datroway-approved-metastatic-tnbc 2026-07-01T14:46:45.957Z weekly 0.7 https://novapharmanews.com/eu/news/x4-pharmaceuticals-ema-chmp-positive-opinion-mavorixafor 2026-07-01T18:14:29.866Z weekly 0.7 https://novapharmanews.com/us/news/fda-declines-guidance-foreign-drug-imports 2026-06-30T06:33:10.244Z weekly 0.7 https://novapharmanews.com/eu/news/privosegtor-ema-prime-optic-neuritis 2026-06-30T15:13:28.955Z weekly 0.7 https://novapharmanews.com/eu/news/arrowhead-pharmaceuticals-positive-cardiometabolic-data-european-a 2026-07-01T15:13:21.581Z weekly 0.7 https://novapharmanews.com/eu/news/teva-olan-ema-acceptance 2026-07-01T14:49:04.754Z weekly 0.7 https://novapharmanews.com/eu/news/florian-lordick-esmo-president-2026-elections-open 2026-07-01T19:40:20.783Z weekly 0.7 https://novapharmanews.com/us/news/ophthalmology-pipeline-milestones-q2-2026 2026-06-30T14:57:56.836Z weekly 0.7 https://novapharmanews.com/eu/news/ema-approves-novo-wegovy-weight-loss-drug 2026-07-01T20:20:12.932Z weekly 0.7 https://novapharmanews.com/us/news/vir-biotechnology-stock-board-reshuffle-governance-votes 2026-06-30T17:27:35.854Z weekly 0.7 https://novapharmanews.com/apac/news/big-pharma-china-trials-scrutiny-oncology 2026-07-01T00:04:28.385Z weekly 0.7 https://novapharmanews.com/apac/news/premia-lind-lind-asia-ai-clinical-trials 2026-07-01T04:32:13.510Z weekly 0.7 https://novapharmanews.com/eu/news/definitive-trial-milestone-50-percent-recruitment 2026-07-01T08:12:42.692Z weekly 0.7 https://novapharmanews.com/apac/news/kissei-pharmaceutical-halts-tavneos-use-amid-deaths 2026-07-01T14:15:21.444Z weekly 0.7 https://novapharmanews.com/us/news/strengths-and-limitations-of-real-world-data-from-electronic-health-records-and-92ed37a9 2026-06-30T22:37:41.951Z weekly 0.7 https://novapharmanews.com/us/news/the-common-fund-data-ecosystem-cfde-449d7791 2026-06-29T21:33:52.293Z weekly 0.7 https://novapharmanews.com/us/news/the-gross-to-net-squeeze-how-physician-led-patient-education-reduces-gtn-erosion-17169d71 2026-06-30T16:53:08.765Z weekly 0.7 https://novapharmanews.com/us/news/a-secure-and-intelligent-drug-delivery-model-integrating-neural-networks-with-bl-853eecb6 2026-07-01T15:02:36.814Z weekly 0.7 https://novapharmanews.com/us/news/the-market-for-monoclonal-antibodies-trends-challenges-and-opportunities-7a342d06 2026-06-28T22:07:20.447Z weekly 0.7 https://novapharmanews.com/us/news/opinion-the-medical-billing-ai-arms-race-between-providers-and-insurance 2026-07-01T06:59:32.960Z weekly 0.7 https://novapharmanews.com/us/news/amish-healthcare-lessons-public-health 2026-06-30T18:17:55.520Z weekly 0.7 https://novapharmanews.com/us/news/nih-funding-cuts-ebola-preparedness-global-health 2026-07-01T05:01:39.497Z weekly 0.7 https://novapharmanews.com/us/news/ultra-processed-food-policy-demands-escalate-researchers-cite-systemic-issues 2026-06-20T19:48:00.877Z weekly 0.7 https://novapharmanews.com/apac/news/pmda-approves-new-pharmaceuticals-medical-devices-whats-new 2026-07-01T08:00:19.062Z weekly 0.7 https://novapharmanews.com/eu/news/eu-trade-policy-china-pharma-analysis 2026-06-30T11:56:01.386Z weekly 0.7 https://novapharmanews.com/eu/news/ema-january-drug-approvals-2025 2026-06-29T21:43:01.745Z weekly 0.7 https://novapharmanews.com/eu/news/chmp-drug-approvals-analysis 2026-07-01T15:01:43.685Z weekly 0.7 https://novapharmanews.com/us/news/munck-wilson-mandala-fort-worth-life-sciences-expansion 2026-06-30T07:47:33.563Z weekly 0.7 https://novapharmanews.com/us/news/fulcrum-therapeutics-stock-plunges-sickle-cell-drug-discontinuation 2026-07-01T05:52:21.041Z weekly 0.7 https://novapharmanews.com/us/news/senior-nih-scientist-research-fellow-charged-with-bringing-deactivated-mpox-virus-into-u-s 2026-06-18T23:38:03.169Z weekly 0.7 https://novapharmanews.com/us/news/cambridge-biotech-merger-acquisition-market-analysis 2026-07-01T12:27:02.495Z weekly 0.7 https://novapharmanews.com/us/news/outlook-therapeutics-lytenava-fda-resubmission-60-day-review 2026-07-01T14:40:07.956Z weekly 0.7 https://novapharmanews.com/us/news/hanmi-signs-licensing-deal-lilly-sonefpeglutide 2026-07-01T11:20:39.257Z weekly 0.7 https://novapharmanews.com/us/news/fda-final-guidance-pulmonary-tuberculosis-drug-development 2026-06-30T04:47:58.116Z weekly 0.7 https://novapharmanews.com/us/news/stat-pharmalittle-lilly-340b-ebola-vaccine-funding 2026-06-29T14:52:30.416Z weekly 0.7 https://novapharmanews.com/us/news/why-us-manufactured-pharmaceutical-packaging-equipment-matters 2026-06-30T17:45:30.956Z weekly 0.7 https://novapharmanews.com/us/news/virtual-end-doctors-office-waiting-room 2026-07-01T01:52:57.717Z weekly 0.7 https://novapharmanews.com/us/news/how-one-state-s-medical-meal-program-lowered-health-care-costs 2026-06-30T19:39:46.924Z weekly 0.7 https://novapharmanews.com/us/news/stat-corporate-medicine-telehealth-crackdown 2026-06-30T18:07:02.203Z weekly 0.7 https://novapharmanews.com/apac/news/global-rwe-guidance-regulatory-decision-making-updates 2026-07-01T19:17:09.901Z weekly 0.7 https://novapharmanews.com/apac/news/china-oncology-research-europe-alarm 2026-06-28T04:59:37.997Z weekly 0.7 https://novapharmanews.com/apac/news/asco-2026-asian-oncology-innovation-clinical-trials 2026-07-01T09:51:17.287Z weekly 0.7 https://novapharmanews.com/us/news/fda-expands-market-access-ends-products 2026-07-01T19:17:05.923Z weekly 0.7 https://novapharmanews.com/us/news/lilly-gilead-pharma-ma-boom-market-analysis 2026-07-01T16:46:11.536Z weekly 0.7 https://novapharmanews.com/us/news/longeveron-stockholder-letter-corporate-strategy-2026-goals 2026-07-01T13:26:01.484Z weekly 0.7 https://novapharmanews.com/eu/news/mayer-brown-serb-pharmaceuticals-idefirix-acquisition 2026-07-01T13:10:24.414Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-atezolizumab-ctdna-mrd-positive-mibc 2026-07-01T12:06:54.829Z weekly 0.7 https://novapharmanews.com/apac/news/beone-medicines-phase-3-herizon-gea-data-nejm 2026-07-01T09:11:45.669Z weekly 0.7 https://novapharmanews.com/eu/news/datroway-priority-review-metastatic-tnbc 2026-07-01T06:06:27.798Z weekly 0.7 https://novapharmanews.com/apac/news/dishman-carbogen-amcis-shanghai-nmpa-gmp-audit 2026-07-01T00:56:25.634Z weekly 0.7 https://novapharmanews.com/us/news/fda-draft-guidance-biosimilar-pk-studies 2026-06-30T20:11:56.814Z weekly 0.7 https://novapharmanews.com/us/news/inventiva-leadership-lanifibranor-phase-3-data 2026-06-30T19:29:39.397Z weekly 0.7 https://novapharmanews.com/apac/news/newron-pharmaceuticals-june-investor-conferences 2026-06-30T15:40:12.369Z weekly 0.7 https://novapharmanews.com/apac/news/hong-kong-new-drug-approval-process 2026-06-30T15:27:50.570Z weekly 0.7 https://novapharmanews.com/eu/news/fda-approves-aldosterone-synthase-inhibitor-hypertension 2026-06-30T15:00:35.931Z weekly 0.7 https://novapharmanews.com/us/news/new-fda-approach-drug-prices-implications 2026-06-30T05:29:45.948Z weekly 0.7 https://novapharmanews.com/eu/news/italy-fourth-europe-clinical-research-enrollment 2026-06-25T11:54:55.386Z weekly 0.7 https://novapharmanews.com/eu/news/ema-implements-new-eu-pharma-rules-regulatory-updates 2026-06-30T22:30:48.176Z weekly 0.7 https://novapharmanews.com/eu/news/regeneron-pharma-ema-eye-drug-review-wolfe-target-trim 2026-06-30T00:11:11.790Z weekly 0.7 https://novapharmanews.com/eu/news/teva-olanzapine-lai-ema-review-schizophrenia 2026-07-01T14:29:03.004Z weekly 0.7 https://novapharmanews.com/eu/news/asco-2026-european-pharma-astrazeneca-roche-market-analysis 2026-07-01T11:46:38.574Z weekly 0.7 https://novapharmanews.com/eu/news/esmo-2025-nmi-bladder-cancer-highlights 2026-06-15T19:57:12.105Z weekly 0.7 https://novapharmanews.com/eu/news/datroway-trodelvy-first-line-tnbc-battle 2026-07-01T15:48:02.927Z weekly 0.7 https://novapharmanews.com/us/news/citius-pharmaceuticals-stock-update-cancer-anti-infective 2026-07-01T10:57:07.438Z weekly 0.7 https://novapharmanews.com/eu/news/idorsia-c-diff-vaccine-clinical-progress 2026-06-29T17:58:12.860Z weekly 0.7 https://novapharmanews.com/us/news/fda-guidance-animal-thyroid-products-august-2026 2026-06-30T10:12:59.843Z weekly 0.7 https://novapharmanews.com/us/news/global-regulatory-roundup-june-1-2026 2026-07-01T20:22:32.237Z weekly 0.7 https://novapharmanews.com/us/news/biotech-m-and-a-trends-2026-outlook 2026-07-01T18:31:08.134Z weekly 0.7 https://novapharmanews.com/us/news/big-pharma-small-deals-biotech-boon 2026-06-30T22:33:18.966Z weekly 0.7 https://novapharmanews.com/us/news/rallybio-avenzo-reverse-merger-oncology-deal 2026-07-01T17:57:16.174Z weekly 0.7 https://novapharmanews.com/us/news/legend-biotech-asco-data-carvykti-lb2102 2026-07-01T19:56:44.387Z weekly 0.7 https://novapharmanews.com/us/news/cdc-ebola-containment-clinical-trials-priority 2026-07-01T18:32:14.346Z weekly 0.7 https://novapharmanews.com/us/news/asia-biopharma-innovation-epicenter-drug-approvals 2026-07-01T04:49:08.235Z weekly 0.7 https://novapharmanews.com/us/news/dea-reschedules-marijuana-schedule-iii-expediting-medical-access-research 2026-06-30T22:39:52.200Z weekly 0.7 https://novapharmanews.com/us/news/fda-expert-panel-review-peptide-access-compounded-drug-market 2026-06-30T15:48:30.408Z weekly 0.7 https://novapharmanews.com/us/news/elite-pharma-fda-anda-generic-anticoagulant-26b 2026-06-30T16:55:58.076Z weekly 0.7 https://novapharmanews.com/us/news/cms-finalizes-medicaid-work-requirement-rules 2026-06-30T17:45:03.954Z weekly 0.7 https://novapharmanews.com/us/news/medicus-pharma-biotech-showcase-2026 2026-07-01T18:28:19.075Z weekly 0.7 https://novapharmanews.com/us/news/rigel-pharmaceuticals-licenses-veppanu 2026-07-01T15:43:42.196Z weekly 0.7 https://novapharmanews.com/us/news/fda-ai-clinical-trials-rfi-guide 2026-06-30T13:22:13.328Z weekly 0.7 https://novapharmanews.com/apac/news/estado-actual-y-acciones-para-impulsar-la-investigacion-clinica-en-mexico-2025-5b7db092 2026-06-30T18:18:26.685Z weekly 0.7 https://novapharmanews.com/us/news/formycon-ag-geschaftsbericht-2025-5ff7fa30 2026-07-01T03:50:34.879Z weekly 0.7 https://novapharmanews.com/us/news/fda-approvals-oncology-jan-mar-2026 2026-07-01T18:33:24.963Z monthly 0.5 https://novapharmanews.com/us/news/eli-lilly-acquires-centessa-pharmaceuticals-market-analysis 2026-07-01T14:50:12.916Z monthly 0.5 https://novapharmanews.com/us/news/bayer-acquisition-eye-drug-biotech 2026-07-01T14:19:26.827Z monthly 0.5 https://novapharmanews.com/us/news/top-10-takeover-targets-2026 2026-07-01T04:52:31.914Z monthly 0.5 https://novapharmanews.com/us/news/us-fda-proposes-regulations-weight-loss-drug-compounding 2026-07-01T03:55:19.972Z monthly 0.5 https://novapharmanews.com/us/news/sunlight-glp-1-2026-fda-decision-compounded-semaglutide 2026-07-01T02:54:32.348Z monthly 0.5 https://novapharmanews.com/us/news/fda-eases-restrictions-peptides-drug-approvals 2026-07-01T01:11:55.430Z monthly 0.5 https://novapharmanews.com/us/news/top-biotech-gainers-codx-nrxp-nvax-clinical-trials-update 2026-06-30T16:50:26.609Z monthly 0.5 https://novapharmanews.com/us/news/fda-easing-restrictions-unproven-peptides 2026-06-28T06:13:15.637Z monthly 0.5 https://novapharmanews.com/us/news/fda-permanent-ban-compounded-glp-1s 2026-06-24T05:31:10.885Z monthly 0.5 https://novapharmanews.com/us/news/fda-peptides-bulk-drug-compounding 2026-06-23T17:12:36.870Z monthly 0.5 https://novapharmanews.com/us/news/2025-drug-approvals-biopharma-resilience 2026-06-15T19:57:12.105Z monthly 0.5 https://novapharmanews.com/eu/news/bio-pharma-outlook-2026-regulatory-updates 2026-07-01T12:29:27.959Z monthly 0.5 https://novapharmanews.com/eu/news/rethinking-qa-qc-future-bio-pharmaceutical-analysis-2026 2026-07-01T11:07:20.755Z monthly 0.5 https://novapharmanews.com/eu/news/fda-delays-astrazeneca-breast-cancer-drug-review 2026-07-01T08:28:02.409Z monthly 0.5 https://novapharmanews.com/us/news/fda-guidance-next-gen-sequencing-gene-therapy-safety 2026-07-01T04:11:33.539Z monthly 0.5 https://novapharmanews.com/us/news/healthcare-dealmaker-megamergers-2026 2026-07-01T01:56:31.363Z monthly 0.5 https://novapharmanews.com/eu/news/2026-italy-drug-medical-device-litigation-report 2026-06-30T23:11:46.048Z monthly 0.5 https://novapharmanews.com/apac/news/early-access-disparities-innovative-therapies 2026-06-30T11:37:41.747Z monthly 0.5 https://novapharmanews.com/eu/news/international-school-clinical-oncology-annual-congress-2026 2026-06-30T11:30:51.696Z monthly 0.5 https://novapharmanews.com/apac/news/pharmaceuticals-market-size-share-analysis-2034 2026-06-29T19:07:44.996Z monthly 0.5 https://novapharmanews.com/eu/news/ascentage-pharma-eha-2026-clinical-advances 2026-06-29T17:12:13.649Z monthly 0.5 https://novapharmanews.com/us/news/fsma-final-rule-traceability-requirements 2026-06-26T10:20:52.553Z monthly 0.5 https://novapharmanews.com/us/news/china-approves-hernexeos-lung-cancer-treatment 2026-07-01T19:18:07.081Z monthly 0.5 https://novapharmanews.com/us/news/longeveron-q1-2026-financial-results-business-update 2026-07-01T19:11:30.451Z monthly 0.5 https://novapharmanews.com/us/news/altrx-glp-1-review-2026-fda-updates-semaglutide 2026-07-01T18:02:25.454Z monthly 0.5 https://novapharmanews.com/us/news/global-ma-trends-health-industries-2026-outlook 2026-07-01T09:18:09.263Z monthly 0.5 https://novapharmanews.com/us/news/wockhardt-us-fda-approval-zaynich 2026-06-30T13:45:25.695Z monthly 0.5 https://novapharmanews.com/us/news/fda-decisions-q2-2026-drug-approvals 2026-06-30T00:21:45.052Z monthly 0.5 https://novapharmanews.com/us/news/pennsylvania-compounding-pharmacy-fda-warning-letter 2026-06-27T18:23:44.726Z monthly 0.5 https://novapharmanews.com/us/news/chinese-pharma-innovators-global-expansion 2026-06-19T08:18:23.396Z monthly 0.5 https://novapharmanews.com/us/news/resilience-reinvention-biotech-maturity 2026-06-15T19:57:12.105Z monthly 0.5 https://novapharmanews.com/eu/news/lenz-therapeutics-vizz-ema-presbyopia 2026-07-01T19:18:01.133Z monthly 0.5 https://novapharmanews.com/eu/news/innovent-pfizer-cancer-drug-deal 2026-07-01T14:43:38.086Z monthly 0.5 https://novapharmanews.com/apac/news/innovative-oncology-pharma-china 2026-07-01T13:40:07.999Z monthly 0.5 https://novapharmanews.com/eu/news/arrowhead-pharmaceuticals-positive-clinical-data-eas-congress 2026-07-01T12:31:04.315Z monthly 0.5 https://novapharmanews.com/apac/news/asia-pacific-eclinical-solutions-market-report-2025-2030 2026-07-01T11:06:17.173Z monthly 0.5 https://novapharmanews.com/us/news/lilly-38b-investment-infectious-disease-portfolio 2026-07-01T01:53:18.791Z monthly 0.5 https://novapharmanews.com/apac/news/uk-clinical-trials-oncology-impact 2026-07-01T00:09:21.583Z monthly 0.5 https://novapharmanews.com/apac/news/biomarkers-digital-technologies-oncology-asia-2026 2026-06-30T16:43:49.608Z monthly 0.5 https://novapharmanews.com/eu/news/innovent-biologics-shares-surge-pfizer-deal 2026-06-30T14:25:26.446Z monthly 0.5 https://novapharmanews.com/us/news/fda-device-guidance-agenda-2026 2026-06-26T08:27:32.593Z monthly 0.5 https://novapharmanews.com/us/news/fda-new-guidance-ai-regulatory-restraint 2026-06-16T22:53:40.481Z monthly 0.5 https://novapharmanews.com/us/news/lunai-bioworks-brainstorm-therapeutics-ai-collaboration 2026-07-01T07:28:36.891Z monthly 0.5 https://novapharmanews.com/us/news/ai-breast-cancer-risk-prediction-tool-fda-approval 2026-07-01T20:15:58.537Z monthly 0.5 https://novapharmanews.com/us/news/regulatory-actions-may-2026 2026-07-01T17:56:20.287Z monthly 0.5 https://novapharmanews.com/us/news/big-pharma-biotech-assets-patent-cliff 2026-07-01T13:42:42.909Z monthly 0.5 https://novapharmanews.com/us/news/bizengri-fda-national-priority-rare-bile-duct-cancer 2026-06-30T12:45:38.284Z monthly 0.5 https://novapharmanews.com/us/news/pharmtech-regulatory-roundup-may-2026-drug-approvals 2026-06-30T08:42:43.304Z monthly 0.5 https://novapharmanews.com/us/news/fda-commissioner-resignation-drug-approvals 2026-06-30T08:36:02.724Z monthly 0.5 https://novapharmanews.com/us/news/states-confront-medical-chatbots-oversight-fda-inaction 2026-06-29T16:40:54.631Z monthly 0.5 https://novapharmanews.com/us/news/ai-brain-organoids-parkinsons-rare-epilepsy-regulatory-updates 2026-06-28T16:19:38.792Z monthly 0.5 https://novapharmanews.com/us/news/life-sciences-dealmaking-momentum-strategic-pressures 2026-06-25T15:37:19.062Z monthly 0.5 https://novapharmanews.com/us/news/big-pharma-ma-spree-march-ipo-drought 2026-06-15T21:29:29.593Z monthly 0.5 https://novapharmanews.com/us/news/pharma-ma-boom-2026-market-analysis 2026-06-15T19:57:12.105Z monthly 0.5 https://novapharmanews.com/eu/news/merz-therapeutics-kvvit-inbrija-agreement 2026-07-01T18:26:00.820Z monthly 0.5 https://novapharmanews.com/apac/news/innovent-biologics-pfizer-10-5b-oncology-partnership 2026-07-01T18:06:23.064Z monthly 0.5 https://novapharmanews.com/eu/news/prac-meeting-highlights-may-2026 2026-07-01T17:40:18.943Z monthly 0.5 https://novapharmanews.com/eu/news/esmo-2025-preview-astra-daiichi-gilead 2026-07-01T15:21:56.608Z monthly 0.5 https://novapharmanews.com/eu/news/critical-medicines-act-council-parliament-deal 2026-07-01T13:59:52.554Z monthly 0.5 https://novapharmanews.com/eu/news/2026-cell-therapy-regulatory-landscape 2026-07-01T12:30:18.597Z monthly 0.5 https://novapharmanews.com/apac/news/clinical-trials-market-oncology-2034 2026-07-01T10:38:31.556Z monthly 0.5 https://novapharmanews.com/eu/news/imfinzi-fda-approval-bladder-cancer 2026-06-30T23:43:18.869Z monthly 0.5 https://novapharmanews.com/apac/news/onconic-therapeutics-jakubo-phase-3-clinical-trials-china 2026-06-30T05:23:27.930Z monthly 0.5 https://novapharmanews.com/apac/news/premia-lind-ai-clinical-trial-screening-asia-pacific 2026-06-29T23:32:41.495Z monthly 0.5 https://novapharmanews.com/apac/news/sun-pharma-organon-acquisition-market-analysis 2026-07-01T16:22:00.396Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-durvalumab-bcg-high-risk-nmibc 2026-07-01T14:51:30.039Z monthly 0.5 https://novapharmanews.com/us/news/seven-biopharma-trends-2026-clinical-trials 2026-07-01T13:32:09.474Z monthly 0.5 https://novapharmanews.com/apac/news/middle-east-pharma-markets-api-china-2026 2026-07-01T08:20:57.758Z monthly 0.5 https://novapharmanews.com/apac/news/global-drug-discovery-market-2035 2026-06-29T17:51:45.423Z monthly 0.5 https://novapharmanews.com/us/news/experimental-igg4-rd-drug-fda-submission 2026-06-29T16:24:25.343Z monthly 0.5 https://novapharmanews.com/us/news/leap-therapeutics-stock-edges-higher 2026-06-25T19:03:08.203Z monthly 0.5 https://novapharmanews.com/eu/news/critical-medicines-act-europe-medicines-shortages 2026-07-01T15:55:01.136Z monthly 0.5 https://novapharmanews.com/eu/news/ema-management-board-march-2026-clinical-trials 2026-07-01T15:38:16.749Z monthly 0.5 https://novapharmanews.com/apac/news/exosome-based-therapeutics-market-2033-report 2026-07-01T12:55:21.047Z monthly 0.5 https://novapharmanews.com/us/news/us-fda-decision-date-camizestrant-extended 2026-07-01T08:46:42.785Z monthly 0.5 https://novapharmanews.com/eu/news/hansa-licenses-idefirix-serb-133m 2026-07-01T08:46:08.250Z monthly 0.5 https://novapharmanews.com/eu/news/camizestrant-eu-approval-advanced-er-positive-breast-cancer 2026-07-01T08:41:59.015Z monthly 0.5 https://novapharmanews.com/apac/news/regulatory-strategy-reimagined-trends-accelerating-drug-development 2026-06-30T23:51:03.459Z monthly 0.5 https://novapharmanews.com/eu/news/tarsier-pharma-ipo-nyse-listings-expand 2026-06-30T21:29:08.684Z monthly 0.5 https://novapharmanews.com/us/news/gsk-alfasigma-licensing-agreement-servier-acquisition 2026-06-30T18:49:17.084Z monthly 0.5 https://novapharmanews.com/apac/news/ai-tools-clinical-trials-life-sciences 2026-06-30T07:45:19.858Z monthly 0.5 https://novapharmanews.com/us/news/fda-loosens-regulations-digital-health-tools 2026-06-30T04:12:56.899Z monthly 0.5 https://novapharmanews.com/eu/news/imfinzi-approved-bladder-cancer-combo 2026-06-29T09:34:45.109Z monthly 0.5 https://novapharmanews.com/us/news/biopharma-dealmaking-2025-market-analysis 2026-06-19T05:28:28.655Z monthly 0.5 https://novapharmanews.com/apac/news/apac-clinical-trial-growth-oncology 2026-06-18T21:23:08.542Z monthly 0.5 https://novapharmanews.com/us/news/global-firms-china-deals-economic-uncertainty 2026-06-18T06:39:14.805Z monthly 0.5 https://novapharmanews.com/eu/news/european-critical-medicines-act-market-analysis 2026-06-30T23:28:12.646Z monthly 0.5 https://novapharmanews.com/eu/news/ai-accelerates-novo-nordisk-parkinsons-cell-therapy 2026-06-30T21:47:19.003Z monthly 0.5 https://novapharmanews.com/us/news/eli-lilly-acquires-vaccine-developers-38b 2026-06-18T20:06:00.075Z monthly 0.5 https://novapharmanews.com/us/news/fda-restricts-compounding-weight-loss-drugs 2026-07-01T18:53:56.428Z monthly 0.5 https://novapharmanews.com/us/news/fda-guidelines-generic-bioequivalence-oncology 2026-07-01T07:07:43.769Z monthly 0.5 https://novapharmanews.com/apac/news/india-vietnam-relations-diplomatic-push 2026-07-01T04:32:29.635Z monthly 0.5 https://novapharmanews.com/us/news/lifesaving-upgrades-fda-oncology-approvals 2026-07-01T03:37:18.513Z monthly 0.5 https://novapharmanews.com/us/news/top-10-anticipated-drug-launches-2026 2026-07-01T01:32:30.399Z monthly 0.5 https://novapharmanews.com/apac/news/immunotherapy-pet-ct-imaging-demand-australia 2026-06-30T21:26:24.738Z monthly 0.5 https://novapharmanews.com/apac/news/brenus-pharma-stc-1010-fda-acceptance 2026-06-30T16:04:33.565Z monthly 0.5 https://novapharmanews.com/eu/news/may-2026-global-health-wash-funding-opportunities 2026-07-01T16:28:31.961Z monthly 0.5 https://novapharmanews.com/eu/news/ema-fda-good-ai-practice-drug-development 2026-07-01T13:08:17.876Z monthly 0.5 https://novapharmanews.com/us/news/sgs-acquires-keystone-bioanalytical-drug-development 2026-07-01T12:58:56.656Z monthly 0.5 https://novapharmanews.com/eu/news/europe-boost-clinical-trials 2026-07-01T08:47:40.637Z monthly 0.5 https://novapharmanews.com/eu/news/us-eu-pharmaceutical-regulations-concerns 2026-06-30T20:58:20.662Z monthly 0.5 https://novapharmanews.com/eu/news/serd-therapy-anti-proliferative-activity-er-her2-breast-cancer 2026-06-30T15:27:50.487Z monthly 0.5 https://novapharmanews.com/eu/news/fda-real-time-clinical-trials-progress 2026-06-30T07:19:03.551Z monthly 0.5 https://novapharmanews.com/eu/news/eu-draft-deal-essential-medicine-shortages 2026-06-30T05:40:16.844Z monthly 0.5 https://novapharmanews.com/apac/news/nuance-pharma-ind-clearance-actair-china 2026-06-30T03:50:17.749Z monthly 0.5 https://novapharmanews.com/us/news/chinas-licensing-boom-global-pipelines 2026-06-20T20:01:37.984Z monthly 0.5 https://novapharmanews.com/us/news/industry-groups-fda-guidance-form-483 2026-06-15T19:57:12.105Z monthly 0.5 https://novapharmanews.com/us/news/fda-clarifies-3-year-exclusivity-guidance 2026-06-15T19:57:12.105Z monthly 0.5 https://novapharmanews.com/apac/news/bukwang-pharmaceutical-dreamcis-aws-clinical-trials 2026-07-01T19:02:35.892Z monthly 0.5 https://novapharmanews.com/us/news/best-biotech-stocks-may-2026-clinical-trials 2026-07-01T10:07:33.795Z monthly 0.5 https://novapharmanews.com/us/news/fda-vs-ema-camizestrant-controversy 2026-07-01T02:55:41.977Z monthly 0.5 https://novapharmanews.com/eu/news/maat-pharma-q1-2026-business-update 2026-06-30T23:31:50.020Z monthly 0.5 https://novapharmanews.com/us/news/astellas-xtandi-patent-cliff-strategic-moves 2026-06-30T20:01:38.055Z monthly 0.5 https://novapharmanews.com/eu/news/critical-medicines-act-impact-pharmaceutical-manufacturing-europe 2026-06-30T12:47:40.876Z monthly 0.5 https://novapharmanews.com/apac/news/lundbeck-korean-approval-vyepti-oncology-migraine 2026-06-19T01:27:11.912Z monthly 0.5 https://novapharmanews.com/apac/news/60-degrees-pharmaceuticals-tafenoquine-clinical-trial-babesiosis 2026-06-15T19:57:12.105Z monthly 0.5 https://novapharmanews.com/eu/news/esmo-breast-cancer-congress-2026-highlights 2026-07-01T05:15:11.362Z monthly 0.5 https://novapharmanews.com/us/news/fda-new-form-483-response-guidance 2026-06-20T02:01:25.186Z monthly 0.5 https://novapharmanews.com/us/news/fda-drug-approval-decisions-may-2026 2026-07-01T19:37:37.750Z monthly 0.5 https://novapharmanews.com/us/news/biomarin-swot-analysis-rare-disease-competitive-headwinds 2026-07-01T13:14:22.774Z monthly 0.5 https://novapharmanews.com/us/news/liminatus-pharma-innocsai-merger-market-analysis 2026-07-01T12:03:02.599Z monthly 0.5 https://novapharmanews.com/apac/news/clinical-trials-day-2026-oncology-study-growth 2026-06-30T18:46:44.709Z monthly 0.5 https://novapharmanews.com/eu/news/ireland-clinical-trials-eu-comparison 2026-06-28T01:36:07.868Z monthly 0.5 https://novapharmanews.com/apac/news/health-news-round-up-immunotherapy-pcos-clopidogrel-trials 2026-06-15T19:57:12.105Z monthly 0.5 https://novapharmanews.com/eu/news/chmp-meeting-highlights-drug-approvals-april-2026 2026-07-01T18:14:40.846Z monthly 0.5 https://novapharmanews.com/eu/news/european-biotechs-cell-gene-therapy-manufacturing 2026-07-01T18:34:36.229Z monthly 0.5 https://novapharmanews.com/us/news/krystal-biotech-q1-earnings-beat-catalysts-2026-2027 2026-07-01T17:57:39.498Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-17-drugs-continuous-manufacturing 2026-07-01T14:27:51.757Z monthly 0.5 https://novapharmanews.com/eu/news/eu-lawmakers-critical-medicines-act-deal 2026-07-01T01:59:48.424Z monthly 0.5 https://novapharmanews.com/eu/news/efpia-warns-access-gap-us-pricing-reforms 2026-06-30T10:31:10.884Z monthly 0.5 https://novapharmanews.com/us/news/rfk-jr-drug-approval-speed-oncology 2026-06-29T13:37:48.242Z monthly 0.5 https://novapharmanews.com/apac/news/clinical-trials-day-2026-research-rising-oncology 2026-06-21T00:17:03.880Z monthly 0.5 https://novapharmanews.com/us/news/fda-in-flux-may-2026-drug-approvals-update 2026-07-01T15:44:08.660Z monthly 0.5 https://novapharmanews.com/apac/news/kelun-merck-lung-cancer-combo-china-trial 2026-07-01T11:27:18.419Z monthly 0.5 https://novapharmanews.com/us/news/aptar-pharma-fda-research-contract-progress 2026-07-01T06:55:37.658Z monthly 0.5 https://novapharmanews.com/us/news/best-cancer-stocks-2026-investment 2026-06-30T14:17:44.086Z monthly 0.5 https://novapharmanews.com/us/news/fda-guidance-animal-testing-alternatives-concerns 2026-06-30T10:54:41.599Z monthly 0.5 https://novapharmanews.com/us/news/fda-fast-track-oncology-drugs-april-2026 2026-06-30T05:26:12.330Z monthly 0.5 https://novapharmanews.com/eu/news/mhra-consultation-rare-disease-therapy 2026-06-30T01:39:25.613Z monthly 0.5 https://novapharmanews.com/apac/news/ildong-pharmaceutical-stock-earnings-pipeline-insights 2026-06-24T00:38:38.728Z monthly 0.5 https://novapharmanews.com/us/news/biomarin-swot-analysis-rare-disease-biotech 2026-07-01T14:51:53.084Z monthly 0.5 https://novapharmanews.com/eu/news/first-glp-1-gene-therapy-clinical-trial-europe 2026-06-30T18:27:00.764Z monthly 0.5 https://novapharmanews.com/us/news/new-fda-guidance-ends-nicotine-pouches 2026-06-29T13:41:52.483Z monthly 0.5 https://novapharmanews.com/us/news/regeneron-pharma-stock-institutional-buying-insights 2026-07-01T19:05:08.200Z monthly 0.5 https://novapharmanews.com/us/news/takeda-novartis-layoffs-pharma-impact 2026-07-01T16:24:09.036Z monthly 0.5 https://novapharmanews.com/us/news/fda-alert-pulmonology-drug-approvals 2026-06-26T21:08:30.483Z monthly 0.5 https://novapharmanews.com/us/news/2026-pharma-ma-breakout-year 2026-06-25T02:27:07.415Z monthly 0.5 https://novapharmanews.com/us/news/fda-lifting-restrictions-compounded-peptides 2026-06-18T06:52:34.618Z monthly 0.5 https://novapharmanews.com/eu/news/february-batch-novel-medicines-ema-chmp-approval 2026-06-30T22:24:26.009Z monthly 0.5 https://novapharmanews.com/apac/news/zte-partners-china-national-clinical-research-center 2026-06-29T05:32:12.738Z monthly 0.5 https://novapharmanews.com/apac/news/novartis-pluvicto-stronger-psa-responses-prostate-cancer 2026-06-27T00:38:06.926Z monthly 0.5 https://novapharmanews.com/us/news/oct-east-coast-2026-recap 2026-07-01T12:06:25.525Z monthly 0.5 https://novapharmanews.com/eu/news/isct-2026-annual-recap 2026-06-30T19:49:34.682Z monthly 0.5 https://novapharmanews.com/us/news/thma-cpe-circle-2026-recap 2026-06-18T06:49:32.627Z monthly 0.5 https://novapharmanews.com/eu/news/global-pharmacovigilance-reporting-comparative-analysis 2026-06-24T11:07:29.093Z monthly 0.5 https://novapharmanews.com/us/news/fda-bayesian-methodology-drug-development 2026-06-15T19:57:12.105Z monthly 0.5 https://novapharmanews.com/us/news/sellas-nears-key-aml-data-dual-trials 2026-06-15T19:57:12.105Z monthly 0.5 https://novapharmanews.com/eu/news/cma-deal-eu-medicine-supply-chains-analysis 2026-06-30T07:28:24.305Z monthly 0.5 https://novapharmanews.com/apac/news/asia-pacific-regulatory-updates-tga-guidance 2026-06-15T19:57:12.105Z monthly 0.5 https://novapharmanews.com/eu/news/europes-drug-innovation-edge-risk-dutch-industry-group 2026-06-30T22:05:46.291Z monthly 0.5 https://novapharmanews.com/us/news/top-10-biopharma-ma-deals-2025 2026-06-30T17:09:20.983Z monthly 0.5 https://novapharmanews.com/eu/news/future-european-medicine-clinical-research 2026-06-29T23:35:19.736Z monthly 0.5 https://novapharmanews.com/eu/news/breast-cancer-experts-esmo-2026-abstracts-preview 2026-07-01T17:44:34.651Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-atezolizumab-muscle-invasive-bladder-cancer 2026-07-01T12:46:01.757Z monthly 0.5 https://novapharmanews.com/eu/news/q1-2026-life-sciences-law-update-clinical-trials 2026-07-01T08:25:16.786Z monthly 0.5 https://novapharmanews.com/us/news/ma-in-pharmaceuticals-market-analysis 2026-06-29T21:03:13.822Z monthly 0.5 https://novapharmanews.com/eu/news/regulatory-round-up-may-11-2026 2026-07-01T12:39:42.942Z monthly 0.5 https://novapharmanews.com/eu/news/ema-critical-medicines-act-market-analysis 2026-07-01T09:32:58.383Z monthly 0.5 https://novapharmanews.com/us/news/ucb-acquires-antibody-treatment-maker-autoimmune-disease 2026-06-30T11:49:42.124Z monthly 0.5 https://novapharmanews.com/apac/news/asia-bacitracin-ointment-market-analysis-regulatory-updates 2026-06-27T05:29:20.101Z monthly 0.5 https://novapharmanews.com/apac/news/india-cdsco-prior-intimation-system-clinical-trials 2026-06-23T20:37:28.784Z monthly 0.5 https://novapharmanews.com/us/news/big-pharma-ma-mega-year-patent-expiries 2026-06-15T19:57:12.105Z monthly 0.5 https://novapharmanews.com/us/news/regulatory-round-up-fda-cancer-drug-approvals 2026-07-01T15:35:39.092Z monthly 0.5 https://novapharmanews.com/us/news/fda-leadership-changes-crisis-drug-approvals 2026-07-01T08:14:22.847Z monthly 0.5 https://novapharmanews.com/us/news/10-clinical-trials-to-watch-2026 2026-06-30T11:00:05.484Z monthly 0.5 https://novapharmanews.com/us/news/pharma-ma-roundup-april-2026 2026-06-30T03:45:11.265Z monthly 0.5 https://novapharmanews.com/apac/news/the-week-in-pharma-action-reaction-insight-may-15-2026 2026-06-15T19:57:12.105Z monthly 0.5 https://novapharmanews.com/eu/news/europes-biotech-dilemma-discovery-scale-clinical-trials 2026-06-15T19:57:12.105Z monthly 0.5 https://novapharmanews.com/us/news/makary-resigns-fda-commissioner-drug-approvals 2026-07-01T14:51:04.627Z monthly 0.5 https://novapharmanews.com/us/news/fda-oncology-drug-approvals-2026 2026-07-01T19:12:23.346Z monthly 0.5 https://novapharmanews.com/us/news/amgen-inc-stock-lung-cancer-setback-steady-cash-flow 2026-07-01T18:48:53.544Z monthly 0.5 https://novapharmanews.com/eu/news/latest-new-meds-ema-chmp-approval 2026-07-01T15:01:45.105Z monthly 0.5 https://novapharmanews.com/us/news/fda-policy-tracker-2026-psychedelics-regulatory-updates 2026-06-30T21:19:40.101Z monthly 0.5 https://novapharmanews.com/us/news/fda-blocks-melanoma-drug-confusion-makary 2026-06-30T14:09:13.921Z monthly 0.5 https://novapharmanews.com/eu/news/esmo-updates-ovarian-cancer-guidelines 2026-06-29T19:57:56.876Z monthly 0.5 https://novapharmanews.com/us/news/fda-dual-approval-tdxd-her2-early-breast-cancer 2026-06-29T16:15:57.108Z monthly 0.5 https://novapharmanews.com/us/news/four-fda-actions-reshaping-drug-development-2026 2026-06-24T11:43:53.654Z monthly 0.5 https://novapharmanews.com/eu/news/countries-compete-reform-trials-global-sponsors 2026-06-15T19:57:12.105Z monthly 0.5 https://novapharmanews.com/us/news/6-biotechs-next-ma-target 2026-06-15T19:57:12.105Z monthly 0.5 https://novapharmanews.com/apac/news/fierce-pharma-asia-bms-hengrui-takeda-daiichi 2026-07-01T19:19:09.782Z monthly 0.5 https://novapharmanews.com/eu/news/20-posts-not-to-miss-esmo-breast-cancer-congress-2026 2026-07-01T05:38:32.287Z monthly 0.5 https://novapharmanews.com/eu/news/crinetics-palsonify-sales-enrollment-updates 2026-06-26T11:27:04.123Z monthly 0.5 https://novapharmanews.com/us/news/novel-drug-approvals-2026-fda 2026-07-01T19:37:47.060Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-event-daily-roundup 2026-07-01T19:58:10.422Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-event-biotech-innovation-us 2026-07-01T19:58:13.218Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-debuts-for-pharma-insights 2026-07-01T18:28:09.208Z monthly 0.5 https://novapharmanews.com/us/news/dia-2024-regulatory-preview 2026-07-01T17:30:04.975Z monthly 0.5 https://novapharmanews.com/us/news/dia-2024-regulatory-affairs-preview 2026-06-29T07:30:57.446Z monthly 0.5 https://novapharmanews.com/us/news/dia-2024-event-preview 2026-06-30T11:18:18.696Z monthly 0.5 https://novapharmanews.com/us/news/dia-2024-regulatory-conference-preview 2026-07-01T19:10:38.662Z monthly 0.5 https://novapharmanews.com/us/news/bio-it-world-conference-oncology-day-1 2026-07-01T19:58:11.130Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2024-highlights-us 2026-06-30T12:15:03.297Z monthly 0.5 https://novapharmanews.com/us/news/fierce-biotech-week-highlights-trends 2026-07-01T16:33:24.654Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-biotech-research-us 2026-07-01T18:28:02.305Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2026-highlights-us-implications 2026-07-01T08:48:52.915Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-daily-highlights 2026-07-01T19:58:11.189Z monthly 0.5 https://novapharmanews.com/us/news/oct-east-coast-daily-roundup 2026-07-01T00:34:26.995Z monthly 0.5 https://novapharmanews.com/us/news/ispor-2026-cardiology-highlights 2026-07-01T08:15:38.384Z monthly 0.5 https://novapharmanews.com/us/news/us-japan-healthcare-conf-2026-highlights 2026-06-30T11:59:25.392Z monthly 0.5 https://novapharmanews.com/us/news/cog-2024-highlights-trends 2026-07-01T15:09:14.580Z monthly 0.5 https://novapharmanews.com/apac/news/pda-manufacturing-apac-highlights 2026-06-30T16:20:55.819Z monthly 0.5 https://novapharmanews.com/us/news/bionj-biopartnering-conference-highlights 2026-06-30T09:01:27.320Z monthly 0.5 https://novapharmanews.com/us/news/asgct-manufacturing-innovations-day1 2026-06-28T02:34:42.734Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2024-gene-therapy-advancements-day-1-roundup 2026-06-30T17:48:18.337Z monthly 0.5 https://novapharmanews.com/us/news/novo-nordisk-record-q1-revenue-wegovy-ozempic 2026-07-01T19:59:19.430Z monthly 0.5 https://novapharmanews.com/us/news/ispor-2026-cardiology-cost-effectiveness 2026-07-01T02:24:02.695Z monthly 0.5 https://novapharmanews.com/apac/news/pda-apac-manufacturing-innovations-day-1-roundup 2026-06-30T20:37:03.017Z monthly 0.5 https://novapharmanews.com/eu/news/isct-2026-eu-manufacturing-day-1 2026-06-28T19:40:40.033Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2024-day-1-gene-therapy-advancements 2026-07-01T09:13:00.702Z monthly 0.5 https://novapharmanews.com/us/news/oct-east-coast-day-1-roundup 2026-06-29T19:47:31.765Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2026-day1-us-biotech-trends 2026-06-30T19:42:25.615Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2026-us-biotech-investors 2026-07-01T04:15:44.036Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-gene-therapy-manufacturing-innovations 2026-07-01T18:15:21.318Z monthly 0.5 https://novapharmanews.com/us/news/bionj-biopartnering-conference-day-1-highlights 2026-07-01T17:21:59.101Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-day-1-biotech-innovation 2026-07-01T00:49:42.462Z monthly 0.5 https://novapharmanews.com/apac/news/pda-apac-pharma-manufacturing-day-1-roundup 2026-07-01T18:14:07.290Z monthly 0.5 https://novapharmanews.com/us/news/us-japan-healthcare-2026-day1-policy-tech 2026-07-01T12:33:35.413Z monthly 0.5 https://novapharmanews.com/us/news/ispor-2026-cardiology-day-1-roundup 2026-07-01T17:15:38.169Z monthly 0.5 https://novapharmanews.com/us/news/fierce-biotech-week-innovations-trends 2026-07-01T13:36:06.349Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-daily-roundup 2026-06-30T05:19:19.751Z monthly 0.5 https://novapharmanews.com/apac/news/pda-apac-manufacturing-innovations-day1 2026-06-29T20:29:20.549Z monthly 0.5 https://novapharmanews.com/us/news/us-japan-healthcare-2026-day1-highlights 2026-07-01T02:29:28.004Z monthly 0.5 https://novapharmanews.com/apac/news/pda-apac-manufacturing-day-1-roundup 2026-07-01T10:50:44.266Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-manufacturing-day-1-roundup 2026-06-29T20:16:32.819Z monthly 0.5 https://novapharmanews.com/us/news/thma-cpe-circle-highlights-key-trends 2026-06-30T17:58:21.603Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-highlights 2026-07-01T13:51:52.272Z monthly 0.5 https://novapharmanews.com/apac/news/apac-clinical-event-preview 2026-07-01T02:29:25.035Z monthly 0.5 https://novapharmanews.com/eu/news/isct-2026-eu-manufacturing-day-1-roundup 2026-07-01T04:16:04.682Z monthly 0.5 https://novapharmanews.com/us/news/asgct-manufacturing-innovations 2026-07-01T12:44:43.197Z monthly 0.5 https://novapharmanews.com/us/news/thma-cpe-circle-daily-roundup 2026-07-01T08:26:04.160Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2024-gene-therapy-advancements 2026-07-01T09:33:25.085Z monthly 0.5 https://novapharmanews.com/us/news/thma-oncology-forum-highlights-us 2026-07-01T07:12:19.586Z monthly 0.5 https://novapharmanews.com/us/news/fdli-2026-annual-highlights 2026-07-01T08:10:11.097Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-highlights-innovations 2026-07-01T11:56:31.223Z monthly 0.5 https://novapharmanews.com/us/news/APHL-2026-annual-day-1-roundup 2026-07-01T05:26:18.165Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-day-1-highlights 2026-06-30T10:53:50.864Z monthly 0.5 https://novapharmanews.com/eu/news/european-research-revolution-key-takeaways 2026-06-24T13:20:09.300Z monthly 0.5 https://novapharmanews.com/us/news/ipec-annual-meeting-highlights-us 2026-07-01T10:26:31.424Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-updates 2026-06-30T18:47:55.244Z monthly 0.5 https://novapharmanews.com/us/news/fdli-annual-2026-daily-roundup 2026-06-30T21:35:46.181Z monthly 0.5 https://novapharmanews.com/us/news/fdli-annual-2026-regulatory-insights-policy-updates 2026-06-30T07:53:56.987Z monthly 0.5 https://novapharmanews.com/us/news/thma-oncology-forum-day-1-roundup 2026-07-01T04:19:27.813Z monthly 0.5 https://novapharmanews.com/eu/news/swiss-biotech-day-key-innovations-partnerships 2026-07-01T13:24:32.475Z monthly 0.5 https://novapharmanews.com/eu/news/european-research-revolution-day-1-highlights 2026-06-27T09:53:11.072Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-updates-day-1 2026-06-30T06:11:09.616Z monthly 0.5 https://novapharmanews.com/apac/news/cryoport-q1-2026-financial-results-clinical-trials-cell-gene-therapy 2026-06-29T19:45:30.335Z monthly 0.5 https://novapharmanews.com/apac/news/ascidian-acdn-01-stellar-trial-stargardt-disease-dose-escalation-complete 2026-07-01T13:10:17.510Z monthly 0.5 https://novapharmanews.com/apac/news/quiver-bioscience-nih-heal-grant-qv-2421-chronic-pain-trials 2026-07-01T08:30:41.389Z monthly 0.5 https://novapharmanews.com/apac/news/lunai-bioworks-20-million-cns-drug-delivery-alzheimer-treatment 2026-07-01T19:18:25.459Z monthly 0.5 https://novapharmanews.com/apac/news/stryker-australia-tga-approval-temporomandibular-joint-prosthesis 2026-07-01T19:45:34.708Z monthly 0.5 https://novapharmanews.com/apac/news/tga-section-41hd-medical-device-emergency-import-approvals-australia 2026-06-29T21:21:27.342Z monthly 0.5 https://novapharmanews.com/eu/news/biotheryx-btx-9341-phase-1a-results-esmo-breast-cancer-congress-2026 2026-07-01T07:40:32.233Z monthly 0.5 https://novapharmanews.com/us/news/palvella-qtorin-rapamycin-phase-2-trial-angiokeratomas 2026-06-30T21:30:28.023Z monthly 0.5 https://novapharmanews.com/us/news/neurocrine-biosciences-nbip-2118-phase-1-obesity-trial 2026-07-01T07:47:00.273Z monthly 0.5 https://novapharmanews.com/us/news/caplyta-lumateperone-tops-adjunctive-depression-treatments-meta-analysis 2026-06-30T22:47:01.556Z monthly 0.5 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0802-phase-2a-trial-steroid-refractory-gvhd 2026-07-01T19:09:32.796Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-guardant360-cdx-veppanu-breast-cancer-diagnostic 2026-07-01T15:43:07.863Z monthly 0.5 https://novapharmanews.com/us/news/opus-genetics-opgx-lca5-fda-rare-disease-evidence-program 2026-07-01T00:05:54.950Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-2026-day-1-roundup 2026-06-30T08:21:22.911Z monthly 0.5 https://novapharmanews.com/eu/news/heart-failure-2026-vutrisiran-data-european-pharma-news 2026-07-01T00:22:40.127Z monthly 0.5 https://novapharmanews.com/apac/news/telix-tlx250-px-zircaix-kidney-cancer-diagnosis-phase-3-zircon 2026-07-01T01:25:59.685Z monthly 0.5 https://novapharmanews.com/apac/news/mifepristone-access-supreme-court-hold-planned-parenthood-5th-circuit 2026-06-30T21:06:27.107Z monthly 0.5 https://novapharmanews.com/eu/news/cvrx-benefit-hf-trial-barostim-heart-failure-first-patient 2026-07-01T02:25:02.408Z monthly 0.5 https://novapharmanews.com/eu/news/agenus-q1-2026-financial-report-botensilimab-balstilimab-update 2026-07-01T01:52:16.341Z monthly 0.5 https://novapharmanews.com/eu/news/oncolytics-biotech-pelareorep-colorectal-cancer-durable-responses 2026-07-01T15:19:11.255Z monthly 0.5 https://novapharmanews.com/eu/news/crispr-therapeutics-q1-2026-casgevy-global-approval 2026-07-01T19:13:55.107Z monthly 0.5 https://novapharmanews.com/us/news/takeda-tak-881-positive-phase-2-3-results-primary-immunodeficiency-disease 2026-07-01T14:53:39.921Z monthly 0.5 https://novapharmanews.com/us/news/accord-healthcare-relaunches-tadalafil-tablets-generic-ed-treatment 2026-07-01T10:16:44.023Z monthly 0.5 https://novapharmanews.com/us/news/inspiremd-fda-approval-switchguard-neuro-protection-cguardians-iii-trial 2026-07-01T19:44:49.619Z monthly 0.5 https://novapharmanews.com/apac/news/spontan-phase-ii-data-10-minute-onset-fda-requirements-erectile-dysfunction 2026-06-29T20:40:33.450Z monthly 0.5 https://novapharmanews.com/apac/news/ironwood-pharmaceuticals-short-bowel-syndrome-tpn-survey-ddw-2026 2026-07-01T10:03:37.084Z monthly 0.5 https://novapharmanews.com/apac/news/novo-nordisk-wegovy-china-launch-eli-lilly-obesity-market 2026-07-01T18:03:19.839Z monthly 0.5 https://novapharmanews.com/apac/news/arrowhead-pharmaceuticals-tga-approval-redemplo-plozasiran-australia-fcs 2026-06-30T17:38:12.250Z monthly 0.5 https://novapharmanews.com/apac/news/biomarin-palynziq-fda-approval-adolescent-pku-patients 2026-07-01T15:01:50.670Z monthly 0.5 https://novapharmanews.com/apac/news/rois-us-expansion-global-cdmo-fda-approval-injectable-manufacturing 2026-07-01T12:50:32.444Z monthly 0.5 https://novapharmanews.com/apac/news/fda-approves-travere-filspari-fsgs-treatment-adults-children 2026-07-01T10:25:17.036Z monthly 0.5 https://novapharmanews.com/eu/news/vanda-pharmaceuticals-nereus-tradipitant-motion-sickness-drug-launch 2026-07-01T16:06:25.950Z monthly 0.5 https://novapharmanews.com/eu/news/takeda-tak-881-phase-3-trial-primary-immunodeficiency-disease-results 2026-07-01T14:53:39.885Z monthly 0.5 https://novapharmanews.com/eu/news/pulse-biosciences-atrial-fibrillation-treatment-100-percent-success-rate-2026 2026-07-01T08:32:22.742Z monthly 0.5 https://novapharmanews.com/eu/news/sq-innovation-lasix-onyu-subcut-hf-ii-trial-results-heart-failure-2026 2026-06-30T13:45:58.025Z monthly 0.5 https://novapharmanews.com/eu/news/krystal-biotech-q1-2026-results-vyjuvek-expansion-registrational-studies 2026-07-01T20:05:59.184Z monthly 0.5 https://novapharmanews.com/eu/news/acurx-dna-pol-iiic-inhibitors-microbiome-preservation-mrsa-escmid-2026 2026-06-30T12:16:23.026Z monthly 0.5 https://novapharmanews.com/eu/news/biocryst-navenibart-european-licensing-deal-neopharmed-gentili 2026-07-01T19:16:14.849Z monthly 0.5 https://novapharmanews.com/eu/news/biosimulation-market-11-billion-2031-drug-development 2026-06-30T20:12:34.128Z monthly 0.5 https://novapharmanews.com/eu/news/grin-therapeutics-phase-3-beeline-study-radiprodil-europe-grin-ndd 2026-07-01T14:29:53.014Z monthly 0.5 https://novapharmanews.com/eu/news/vertex-casgevy-gene-therapy-global-expansion-q1-2026-results 2026-07-01T16:38:27.491Z monthly 0.5 https://novapharmanews.com/eu/news/nuvation-bio-ibtrozi-q1-2026-revenue-ros1-nsclc 2026-07-01T19:46:36.361Z monthly 0.5 https://novapharmanews.com/us/news/crispr-therapeutics-casgevy-global-approvals-60000-patients 2026-07-01T17:46:21.127Z monthly 0.5 https://novapharmanews.com/us/news/clene-cnm-au8-fda-accelerated-approval-pathway-als-treatment 2026-07-01T17:45:30.400Z monthly 0.5 https://novapharmanews.com/us/news/atossa-therapeutics-fda-rare-pediatric-disease-designation-z-endoxifen-mccune-albright-syndrome 2026-07-01T16:41:55.677Z monthly 0.5 https://novapharmanews.com/us/news/mbiota-elemental-ibs-treatment-ddw-2026-clinical-trial 2026-07-01T04:25:46.823Z monthly 0.5 https://novapharmanews.com/us/news/novartis-fabhalta-health-canada-approval-c3g-treatment 2026-06-29T16:22:25.749Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-cellectar-waldenstrom-macroglobulinemia 2026-07-01T02:41:08.789Z monthly 0.5 https://novapharmanews.com/us/news/alpha-tau-alpha-dart-pancreatic-cancer-trials-ddw-2026 2026-07-01T07:19:26.606Z monthly 0.5 https://novapharmanews.com/us/news/cytokinetics-aficamten-phase-3-trial-results-non-obstructive-hypertrophic-cardiomyopathy-may-2026 2026-06-30T14:07:39.451Z monthly 0.5 https://novapharmanews.com/us/news/inflarx-izicopan-reactive-metabolite-liver-safety-study 2026-07-01T07:00:37.954Z monthly 0.5 https://novapharmanews.com/us/news/macrogenics-expands-zynyz-royalty-agreement-sagard-healthcare 2026-06-30T20:24:59.610Z monthly 0.5 https://novapharmanews.com/us/news/akebia-vadadustat-mortality-reduction-kidney-disease-jasn-study 2026-06-29T23:33:44.272Z monthly 0.5 https://novapharmanews.com/us/news/inflarx-izicopan-favorable-liver-metabolism-safety-profile-2026 2026-06-30T22:08:05.351Z monthly 0.5 https://novapharmanews.com/us/news/celcuity-gedatolisib-phase-3-viktoria-1-trial-pik3ca-mutant-cancer 2026-07-01T17:39:28.870Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-langlara-interchangeable-biosimilar-lantus-insulin-lannett 2026-07-01T06:41:47.562Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-incyte-jakafi-xr-extended-release-myelofibrosis 2026-07-01T18:37:02.432Z monthly 0.5 https://novapharmanews.com/us/news/arvinas-veppanu-vepdegestrant-fda-approval-first-protac-drug-esr1-breast-cancer 2026-07-01T18:35:54.036Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-conference-daily-roundup 2026-06-30T18:59:40.424Z monthly 0.5 https://novapharmanews.com/us/news/APHL-2026-annual-meeting-day-1-highlights 2026-07-01T09:32:54.069Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-day-1-roundup 2026-06-30T22:16:48.307Z monthly 0.5 https://novapharmanews.com/eu/news/swiss-biotech-day-daily-roundup 2026-06-30T21:08:42.368Z monthly 0.5 https://novapharmanews.com/apac/news/fda-approves-auvelity-new-mdd-treatment 2026-07-01T10:54:06.029Z monthly 0.5 https://novapharmanews.com/apac/news/sun-pharma-organon-partnership-india 2026-07-01T02:50:26.387Z monthly 0.5 https://novapharmanews.com/eu/news/purdue-pharma-shutdown-oxycontin-settlement 2026-07-01T17:30:57.454Z monthly 0.5 https://novapharmanews.com/eu/news/eular-2026-immutep-imp761-phase-1-preview 2026-07-01T19:01:41.448Z monthly 0.5 https://novapharmanews.com/us/news/thma-pharmacy-growth-priorities-2026 2026-06-30T05:21:42.704Z monthly 0.5 https://novapharmanews.com/us/news/cphi-americas-2026-pharma-manufacturing-trends 2026-07-01T15:52:38.507Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-conference-day-1-highlights 2026-06-30T20:00:54.209Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-day-1-roundup 2026-07-01T01:21:30.671Z monthly 0.5 https://novapharmanews.com/apac/news/ucb-acquires-candid-therapeutics-2-2-billion-t-cell-engager-autoimmune 2026-07-01T12:55:57.758Z monthly 0.5 https://novapharmanews.com/eu/news/novelty-nobility-agc-biologics-bispecific-antibody-manufacturing-partnership 2026-06-30T05:10:43.958Z monthly 0.5 https://novapharmanews.com/eu/news/smartee-denti-technology-mandibular-repositioning-eas-congress-2026 2026-06-29T21:03:36.669Z monthly 0.5 https://novapharmanews.com/us/news/xtalpi-pep08-prmt5-inhibitor-phase-1-cancer-trial-enrollment 2026-07-01T12:16:58.507Z monthly 0.5 https://novapharmanews.com/us/news/mirum-pharmaceuticals-vistas-volixibat-primary-sclerosing-cholangitis-results-may-2026 2026-07-01T15:58:56.721Z monthly 0.5 https://novapharmanews.com/us/news/everads-therapy-suprachoroidal-injector-clinical-data-ophthalmology-science 2026-06-30T14:56:55.398Z monthly 0.5 https://novapharmanews.com/us/news/ucb-acquires-candid-therapeutics-autoimmune-deal 2026-07-01T05:56:20.525Z monthly 0.5 https://novapharmanews.com/us/news/spinogenix-tazbentetol-neuroprotective-glaucoma-diabetic-retinopathy-arvo-2026 2026-06-30T22:54:12.941Z monthly 0.5 https://novapharmanews.com/us/news/niktimvo-axatilimab-approved-australia-chronic-gvhd-treatment 2026-07-01T03:56:46.822Z monthly 0.5 https://novapharmanews.com/us/news/ipec-annual-meeting-2026-no-pharma-news 2026-06-30T14:19:51.418Z monthly 0.5 https://novapharmanews.com/eu/news/swiss-biotech-day-2026-ai-oncology-microbiome 2026-07-01T10:34:28.925Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-conference-2026-daily-roundup 2026-06-30T20:47:15.709Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-meeting-opens-public-health-lab-focus 2026-06-30T09:29:17.738Z monthly 0.5 https://novapharmanews.com/apac/news/fda-approves-auvelity-mdd-new-antidepressant 2026-07-01T02:21:25.288Z monthly 0.5 https://novapharmanews.com/eu/news/purdue-pharma-dissolution-approved-opioid-crisis 2026-06-30T20:26:08.396Z monthly 0.5 https://novapharmanews.com/eu/news/auvelity-fda-approval-axsome-therapeutics 2026-06-30T20:03:11.444Z monthly 0.5 https://novapharmanews.com/us/news/axsome-fda-approval-alzheimers-agitation 2026-06-30T12:47:33.792Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-first-non-antipsychotic-dementia-agitation 2026-06-30T23:19:10.368Z monthly 0.5 https://novapharmanews.com/apac/news/a2-milk-company-recalls-platinum-infant-formula-health-risk 2026-06-30T18:29:55.705Z monthly 0.5 https://novapharmanews.com/us/news/edwards-lifesciences-resilia-tissue-10-year-durability-aortic-valve-trial 2026-07-01T07:04:25.903Z monthly 0.5 https://novapharmanews.com/us/news/biomarin-voxzogo-achondroplasia-long-term-data-pes-2026 2026-06-30T14:02:45.047Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-incyte-jakafi-xr-extended-release-myelofibrosis-polycythemia-vera 2026-07-01T17:30:42.395Z monthly 0.5 https://novapharmanews.com/apac/news/fda-approves-auvelity-axsome-therapeutics-mdd 2026-07-01T03:56:16.741Z monthly 0.5 https://novapharmanews.com/us/news/plozasiran-tga-approval-australia-redemplo-fcs 2026-07-01T09:54:14.206Z monthly 0.5 https://novapharmanews.com/apac/news/vector-science-therapeutics-microneedle-catheter-patent-intratumoral-drug-delivery 2026-07-01T05:25:17.007Z monthly 0.5 https://novapharmanews.com/apac/news/apotex-generic-ozempic-semaglutide-health-canada-approval-2026 2026-07-01T17:56:21.574Z monthly 0.5 https://novapharmanews.com/apac/news/keenova-terlivaz-terlipressin-clinical-data-digestive-disease-week-2026 2026-07-01T13:31:11.107Z monthly 0.5 https://novapharmanews.com/apac/news/kodiak-sciences-ksi-101-clinical-data-macular-edema-conferences 2026-06-30T12:25:07.185Z monthly 0.5 https://novapharmanews.com/eu/news/synbiotech-microbiome-womens-healthy-aging-vitafoods-2026 2026-07-01T19:06:27.885Z monthly 0.5 https://novapharmanews.com/eu/news/curaleaf-torsten-greif-board-appointment-european-cannabis 2026-07-01T17:52:58.775Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-manufacturing-software-market-787-billion-2030 2026-07-01T09:53:29.929Z monthly 0.5 https://novapharmanews.com/eu/news/goodrx-ozempic-pill-type-2-diabetes-149-monthly 2026-06-30T20:40:12.629Z monthly 0.5 https://novapharmanews.com/us/news/neurocrine-crenessity-two-year-pediatric-cah-study-results 2026-07-01T20:19:01.915Z monthly 0.5 https://novapharmanews.com/us/news/cairn-surgical-breast-cancer-locator-system-pivotal-trial-results 2026-06-29T22:12:58.896Z monthly 0.5 https://novapharmanews.com/us/news/restore-vision-rv-001-gene-therapy-retinitis-pigmentosa-clinical-results 2026-07-01T04:31:21.601Z monthly 0.5 https://novapharmanews.com/us/news/archimed-acquires-esperion-therapeutics-cardiometabolic-deal-2026 2026-07-01T16:21:40.163Z monthly 0.5 https://novapharmanews.com/us/news/oculis-dme-research-arvo-2026-presentation 2026-07-01T04:16:21.406Z monthly 0.5 https://novapharmanews.com/us/news/rhythm-pharmaceuticals-imcivree-european-commission-approval-hypothalamic-obesity 2026-07-01T06:46:31.961Z monthly 0.5 https://novapharmanews.com/us/news/atara-biotherapeutics-ebvallo-fda-complete-response-letter-securities-lawsuit 2026-06-30T03:54:37.537Z monthly 0.5 https://novapharmanews.com/us/news/novo-nordisk-oral-ozempic-fda-approved-pill-glp1-type-2-diabetes-cardiovascular 2026-07-01T17:42:20.123Z monthly 0.5 https://novapharmanews.com/us/news/zeta-surgical-fda-clearance-brain-surgery-navigation-system 2026-07-01T02:36:39.613Z monthly 0.5 https://novapharmanews.com/us/news/viatris-low-dose-estrogen-contraceptive-patch-acog-2026 2026-07-01T19:13:05.297Z monthly 0.5 https://novapharmanews.com/us/news/axsome-auvelity-fda-approval-alzheimers-agitation-treatment 2026-07-01T13:17:55.455Z monthly 0.5 https://novapharmanews.com/us/news/arvinas-fda-approval-veppanu-vepdegestrant-protac-esr1-breast-cancer 2026-07-01T19:17:24.099Z monthly 0.5 https://novapharmanews.com/eu/news/plozasiran-tga-approval-australia-fcs 2026-06-29T20:18:01.678Z monthly 0.5 https://novapharmanews.com/us/news/moderna-fda-talks-phase-4-covid-vaccine-data 2026-06-30T15:36:31.837Z monthly 0.5 https://novapharmanews.com/apac/news/namsa-lexitas-partnership-ophthalmic-medical-device-development 2026-07-01T10:11:38.484Z monthly 0.5 https://novapharmanews.com/apac/news/verified-clinical-trials-chubb-partnership-patient-safety-data-quality 2026-06-15T19:57:12.105Z monthly 0.5 https://novapharmanews.com/apac/news/huahui-health-beone-medicines-hh160-trispecific-antibody-oncology-partnership 2026-06-29T03:41:17.219Z monthly 0.5 https://novapharmanews.com/apac/news/amgen-q1-2026-financial-results-double-digit-growth 2026-06-30T15:00:46.642Z monthly 0.5 https://novapharmanews.com/apac/news/haier-biomedical-international-revenue-growth-2025 2026-07-01T11:23:31.081Z monthly 0.5 https://novapharmanews.com/apac/news/tga-combination-boundary-products-guidance-apac-pharmaceutical 2026-07-01T11:16:07.841Z monthly 0.5 https://novapharmanews.com/apac/news/genprex-israel-patent-reqorsa-gene-therapy-pd1-antibodies-cancer 2026-06-30T12:32:09.040Z monthly 0.5 https://novapharmanews.com/apac/news/prolacta-human-milk-fortifiers-prescription-drug-status-japan-jasmine-trial 2026-06-30T12:40:04.351Z monthly 0.5 https://novapharmanews.com/eu/news/stoke-therapeutics-zorevunersen-dravet-syndrome-q1-2026-results 2026-07-01T02:15:36.124Z monthly 0.5 https://novapharmanews.com/eu/news/uniqure-amt-130-gene-therapy-uk-approval-huntingtons-disease 2026-07-01T18:17:17.519Z monthly 0.5 https://novapharmanews.com/eu/news/northwest-biotherapeutics-annalisa-jenkins-dcvax-cancer-vaccine-adviser 2026-06-30T23:12:37.727Z monthly 0.5 https://novapharmanews.com/eu/news/cerus-intercept-blood-system-european-regulatory-review-phase-3-trials 2026-07-01T01:37:26.407Z monthly 0.5 https://novapharmanews.com/eu/news/bio-rad-q1-2026-ivdr-compliance-costs-european-diagnostics 2026-07-01T19:39:38.161Z monthly 0.5 https://novapharmanews.com/eu/news/alkeus-gildeuretinol-stargardt-disease-arvo-2026-data 2026-07-01T12:40:54.069Z monthly 0.5 https://novapharmanews.com/eu/news/setpoint-medical-multiple-sclerosis-trial-neuroimmune-therapy 2026-06-29T17:23:27.597Z monthly 0.5 https://novapharmanews.com/eu/news/emergent-biosolutions-q1-2026-financial-results 2026-07-01T03:12:58.851Z monthly 0.5 https://novapharmanews.com/eu/news/telix-tlx101-px-pixlumi-brain-cancer-imaging-european-approval 2026-07-01T12:56:44.266Z monthly 0.5 https://novapharmanews.com/us/news/mrm-health-mh002-fda-fast-track-ulcerative-colitis 2026-07-01T13:51:07.923Z monthly 0.5 https://novapharmanews.com/us/news/cadrenal-therapeutics-cad-1005-fda-phase-3-heparin-induced-thrombocytopenia 2026-06-22T12:11:39.372Z monthly 0.5 https://novapharmanews.com/us/news/redhill-rhb-204-comparable-efficacy-rhb-104-crohns-disease-map-treatment 2026-07-01T12:51:15.886Z monthly 0.5 https://novapharmanews.com/us/news/phathom-pharmaceuticals-voquezna-q1-2026-earnings-profitability-guidance 2026-07-01T20:14:24.168Z monthly 0.5 https://novapharmanews.com/us/news/contineum-therapeutics-pipe-791-positive-phase-1b-chronic-pain-results 2026-07-01T12:02:33.158Z monthly 0.5 https://novapharmanews.com/us/news/summit-therapeutics-ivonescimab-overall-survival-lung-cancer-asco-2026 2026-07-01T18:59:11.134Z monthly 0.5 https://novapharmanews.com/us/news/ac-immune-aci-24-alzheimers-trial-final-cohort-aci-19764-phase-1 2026-07-01T07:26:47.336Z monthly 0.5 https://novapharmanews.com/us/news/addex-dipraglurant-brain-injury-recovery-2025-results 2026-06-28T10:30:41.104Z monthly 0.5 https://novapharmanews.com/us/news/ac-immune-final-cohort-abate-trial-anti-abeta-alzheimer-treatment 2026-07-01T01:28:31.472Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-9mw2821-cervical-cancer-esmo-gc-2026 2026-07-01T08:43:15.159Z monthly 0.5 https://novapharmanews.com/us/news/aquestive-therapeutics-securities-fraud-lawsuit-anaphylm-fda-review 2026-07-01T17:45:00.477Z monthly 0.5 https://novapharmanews.com/us/news/fda-advisory-committee-recommends-astrazeneca-truqap-pten-deficient-prostate-cancer 2026-06-30T18:10:19.126Z monthly 0.5 https://novapharmanews.com/us/news/eli-lilly-foundayo-orforglipron-fda-approval-obesity-q1-2026-results 2026-07-01T18:47:21.489Z monthly 0.5 https://novapharmanews.com/us/news/theradaptive-fda-approval-osteoadapt-sp-phase-3-spinal-fusion-trial 2026-07-01T18:56:19.539Z monthly 0.5 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-ai-gene-therapy 2026-07-01T05:59:30.192Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-q1-2026-licensing-deals 2026-07-01T13:19:57.525Z monthly 0.5 https://novapharmanews.com/us/news/fierce-biotech-week-2026-ai-oncology-preview 2026-07-01T19:31:36.471Z monthly 0.5 https://novapharmanews.com/us/news/ipec-excipient-world-biologics-summit-2026-preview 2026-06-30T15:12:55.844Z monthly 0.5 https://novapharmanews.com/apac/news/axoft-55m-series-a-brain-computer-interface-clinical-trials 2026-07-01T00:35:00.916Z monthly 0.5 https://novapharmanews.com/apac/news/vivacta-bio-50-million-series-a-funding-gt801-car-t-therapy 2026-07-01T12:31:24.730Z monthly 0.5 https://novapharmanews.com/apac/news/taimei-technology-ai-clinical-trials-biokorea-2026 2026-07-01T05:18:58.310Z monthly 0.5 https://novapharmanews.com/apac/news/energenesis-energi-f703dfu-diabetic-foot-ulcer-ewma-2026 2026-07-01T11:50:47.372Z monthly 0.5 https://novapharmanews.com/apac/news/ascletis-pharma-diabetes-drug-data-ada-2026-scientific-sessions 2026-07-01T17:37:01.021Z monthly 0.5 https://novapharmanews.com/apac/news/tlx597-tx-psma-radioligand-therapy-optimal-trial-prostate-cancer 2026-06-30T16:59:32.550Z monthly 0.5 https://novapharmanews.com/apac/news/immunitybio-securities-fraud-lawsuit-anktiva-fda-warning-letter 2026-07-01T05:32:08.272Z monthly 0.5 https://novapharmanews.com/eu/news/hutchmed-sovleplenib-priority-review-breakthrough-designation-china-autoimmune-hemolytic-anemia 2026-07-01T14:32:05.628Z monthly 0.5 https://novapharmanews.com/eu/news/fda-real-world-evidence-framework-medtech-ventripoint-10-billion 2026-07-01T05:31:26.159Z monthly 0.5 https://novapharmanews.com/us/news/purespring-therapeutics-nphs2-genetic-variants-adult-onset-fsgs-study 2026-07-01T04:46:30.704Z monthly 0.5 https://novapharmanews.com/us/news/viking-therapeutics-vk2735-phase-3-obesity-trials-enrolled-q1-2026 2026-07-01T20:07:20.247Z monthly 0.5 https://novapharmanews.com/us/news/relay-therapeutics-q1-2026-earnings-zovegalisib-updates-may-5 2026-06-30T19:05:34.575Z monthly 0.5 https://novapharmanews.com/us/news/neurocrine-ingrezza-tardive-dyskinesia-improvement-threshold-study 2026-06-30T12:52:30.751Z monthly 0.5 https://novapharmanews.com/us/news/novo-nordisk-denecimig-hemophilia-a-phase-3-trial-nejm 2026-07-01T07:52:46.254Z monthly 0.5 https://novapharmanews.com/us/news/addex-gabab-pam-ipf-chronic-cough-preclinical-results 2026-07-01T17:59:25.185Z monthly 0.5 https://novapharmanews.com/us/news/iga-nephropathy-market-forecast-2036-novartis-zigakibart-immunotherapies 2026-06-30T03:49:59.650Z monthly 0.5 https://novapharmanews.com/us/news/perimeter-medical-claire-oct-ai-fda-approval-breast-cancer-surgery 2026-07-01T04:35:12.817Z monthly 0.5 https://novapharmanews.com/us/news/regeneron-q1-2026-earnings-dupixent-eylea-hd-sales-growth 2026-07-01T18:49:27.569Z monthly 0.5 https://novapharmanews.com/us/news/sprout-pharmaceuticals-addyi-flibanserin-time-top-10-influential-health-companies-2026 2026-07-01T02:14:21.085Z monthly 0.5 https://novapharmanews.com/eu/news/biopharma-clinical-trials-eu-daily-insights 2026-06-30T16:53:36.366Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-2026-key-takeaways 2026-07-01T16:31:19.548Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-trends-2026-key-takeaways 2026-07-01T18:01:07.416Z monthly 0.5 https://novapharmanews.com/us/news/ieee-cog-2026-industry-day-game-dev-tutorials 2026-07-01T15:48:37.678Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-2026-highlights 2026-07-01T15:55:56.142Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-deals-apac 2026-06-30T16:20:54.706Z monthly 0.5 https://novapharmanews.com/apac/news/insilico-rentosertib-inhalation-ind-clearance-ai-drug-clinical-trial 2026-07-01T18:18:47.335Z monthly 0.5 https://novapharmanews.com/apac/news/thailand-asean-medical-device-market-gateway-2029 2026-07-01T08:30:33.131Z monthly 0.5 https://novapharmanews.com/apac/news/yangtze-river-pharmaceutical-group-international-revenue-growth-2025 2026-07-01T05:28:23.717Z monthly 0.5 https://novapharmanews.com/apac/news/soleno-therapeutics-securities-fraud-lawsuit-phase-3-clinical-trials 2026-07-01T01:21:58.023Z monthly 0.5 https://novapharmanews.com/apac/news/newleos-ntx-2001-phase-1b-trial-alcohol-use-disorder 2026-07-01T04:41:46.949Z monthly 0.5 https://novapharmanews.com/apac/news/citius-oncology-lymphir-first-international-shipment-europe 2026-06-27T21:43:47.567Z monthly 0.5 https://novapharmanews.com/apac/news/eirgenix-japan-biosimilar-expansion-cphi-2026 2026-07-01T19:45:27.932Z monthly 0.5 https://novapharmanews.com/eu/news/european-commission-approves-poherdy-pertuzumab-biosimilar-henlius-organon 2026-07-01T04:39:07.394Z monthly 0.5 https://novapharmanews.com/eu/news/puretech-lyt-200-clinical-results-myeloid-malignancies-2025 2026-06-30T01:06:04.208Z monthly 0.5 https://novapharmanews.com/eu/news/enterobiotix-19m-funding-phase-2b-ibs-microbiome-trial 2026-07-01T13:13:24.111Z monthly 0.5 https://novapharmanews.com/eu/news/ray-therapeutics-rtx-015-ema-prime-designation-retinitis-pigmentosa 2026-07-01T00:53:17.557Z monthly 0.5 https://novapharmanews.com/eu/news/norgine-xolremdi-mavorixafor-european-approval-whim-syndrome-treatment 2026-07-01T19:33:45.200Z monthly 0.5 https://novapharmanews.com/eu/news/ema-expert-panel-covid-19-mrna-vaccine-trust-spikevax-comirnaty 2026-06-30T20:03:27.982Z monthly 0.5 https://novapharmanews.com/eu/news/henlius-organon-poherdy-first-pertuzumab-biosimilar-approved-europe 2026-07-01T14:35:54.316Z monthly 0.5 https://novapharmanews.com/us/news/fda-clinical-hold-newron-evenamide-phase-3-trial-treatment-resistant-schizophrenia 2026-07-01T01:26:49.994Z monthly 0.5 https://novapharmanews.com/us/news/teva-q1-2026-results-ponlimsi-fda-approval-olanzapine-lai 2026-07-01T15:06:15.388Z monthly 0.5 https://novapharmanews.com/us/news/teva-acquires-emalex-ecopipam-tourette-syndrome-drug 2026-07-01T19:33:16.917Z monthly 0.5 https://novapharmanews.com/us/news/teva-ponlimsi-biosimilar-fda-approval-prolia-q1-2026-results 2026-07-01T06:51:37.077Z monthly 0.5 https://novapharmanews.com/us/news/bayer-asundexian-stroke-trial-esoc-2026-abstracts 2026-06-30T11:45:20.219Z monthly 0.5 https://novapharmanews.com/us/news/tempest-therapeutics-tpst-2003-car-t-multiple-myeloma-isct-2026 2026-07-01T09:45:26.803Z monthly 0.5 https://novapharmanews.com/us/news/pfizer-elrexfio-progression-free-survival-multiple-myeloma-phase-3-trial 2026-07-01T14:41:50.916Z monthly 0.5 https://novapharmanews.com/us/news/rein-therapeutics-lti-03-phase-2-trial-enrollment-update-ipf 2026-06-30T13:09:36.324Z monthly 0.5 https://novapharmanews.com/us/news/laguna-biotherapeutics-fda-clearance-lgna-100-pediatric-leukemia-trial 2026-06-30T22:00:58.140Z monthly 0.5 https://novapharmanews.com/us/news/expression-therapeutics-fda-fast-track-hemophilia-a-stem-cell-therapy 2026-06-30T10:06:27.825Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-gilead-bictegravir-lenacapavir-hiv-treatment 2026-07-01T13:21:38.743Z monthly 0.5 https://novapharmanews.com/us/news/regeneron-otarmeni-gene-therapy-free-hearing-loss-government-agreement 2026-07-01T05:26:50.907Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals 2026-07-01T05:04:27.501Z monthly 0.5 https://novapharmanews.com/us/news/cog-2024-daily-highlights 2026-07-01T14:54:05.766Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-deals-investment 2026-07-01T09:15:18.465Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-oncology-data-readouts 2026-07-01T18:56:09.696Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-oncology-trials-preview 2026-07-01T17:22:19.211Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals-day-1 2026-07-01T11:17:58.576Z monthly 0.5 https://novapharmanews.com/apac/news/trialcliniq-150k-investment-caduceus-capital-ai-clinical-trial-recruitment 2026-07-01T02:18:59.756Z monthly 0.5 https://novapharmanews.com/apac/news/argo-biopharma-bw-50218-phase-1-trial-first-patient-sirna-therapy 2026-06-30T03:48:15.552Z monthly 0.5 https://novapharmanews.com/apac/news/claruvis-retoxin-first-recombinant-botulinum-toxin-approval-china 2026-07-01T11:00:10.878Z monthly 0.5 https://novapharmanews.com/apac/news/jyong-biotech-botreso-botanical-drug-market-access-strategy-2026 2026-07-01T15:54:37.465Z monthly 0.5 https://novapharmanews.com/apac/news/arcera-life-sciences-fosun-pharma-neurodegenerative-disease-collaboration 2026-06-30T23:08:11.386Z monthly 0.5 https://novapharmanews.com/apac/news/samsung-bioepis-atlatl-partnership-asia-pacific-biotech-innovation 2026-07-01T07:11:41.089Z monthly 0.5 https://novapharmanews.com/apac/news/tga-implantable-medical-devices-regulatory-framework-australia-2024 2026-06-30T20:15:56.561Z monthly 0.5 https://novapharmanews.com/apac/news/immunic-appoints-michael-panzara-chief-medical-officer-vidofludimus-calcium 2026-06-30T16:04:45.097Z monthly 0.5 https://novapharmanews.com/apac/news/zhengye-biotechnology-fiscal-2025-financial-results-veterinary-vaccines 2026-06-30T01:11:11.482Z monthly 0.5 https://novapharmanews.com/eu/news/vivosim-labs-ai-tool-predicts-drug-diarrhea-without-animal-testing 2026-07-01T18:56:07.479Z monthly 0.5 https://novapharmanews.com/eu/news/boehringer-ingelheim-survodutide-weight-loss-phase-2-trial-results 2026-07-01T08:42:47.694Z monthly 0.5 https://novapharmanews.com/eu/news/idorsia-quviviq-74-percent-sales-growth-q1-2026-european-expansion 2026-07-01T07:00:40.293Z monthly 0.5 https://novapharmanews.com/eu/news/small-molecule-api-market-202-billion-2036-generic-drugs 2026-07-01T06:57:57.217Z monthly 0.5 https://novapharmanews.com/eu/news/silexion-therapeutics-sil204-phase-2-3-trial-kras-pancreatic-cancer 2026-07-01T17:53:35.392Z monthly 0.5 https://novapharmanews.com/eu/news/novo-nordisk-wegovy-data-women-obesity-european-congress-2026 2026-07-01T00:57:02.744Z monthly 0.5 https://novapharmanews.com/eu/news/solid-biosciences-sgt-003-european-orphan-drug-designation-duchenne-muscular-dystrophy 2026-06-30T20:39:50.566Z monthly 0.5 https://novapharmanews.com/eu/news/cytokinetics-myqorzo-aficamten-esc-heart-failure-2026-congress 2026-06-30T11:42:39.842Z monthly 0.5 https://novapharmanews.com/eu/news/artiva-biotherapeutics-allonk-fda-fast-track-rheumatoid-arthritis 2026-07-01T05:48:44.409Z monthly 0.5 https://novapharmanews.com/eu/news/sq-innovation-lasix-onyu-ce-marking-approval-european-market 2026-06-30T19:15:40.923Z monthly 0.5 https://novapharmanews.com/us/news/aop-health-rapiblyk-landiolol-first-patient-treatment-us 2026-06-30T11:24:30.107Z monthly 0.5 https://novapharmanews.com/us/news/emergent-biosolutions-substipharm-japanese-encephalitis-vaccine-manufacturing-partnership 2026-06-30T07:07:35.579Z monthly 0.5 https://novapharmanews.com/us/news/zealand-pharma-survodutide-weight-loss-phase-3-trial-results 2026-07-01T13:23:26.935Z monthly 0.5 https://novapharmanews.com/us/news/ashvattha-therapeutics-migaldendranib-diabetic-macular-edema-amd-data 2026-06-25T13:39:47.372Z monthly 0.5 https://novapharmanews.com/us/news/aclaris-ati-052-phase-1a-trial-results-45-day-half-life 2026-06-30T00:02:05.214Z monthly 0.5 https://novapharmanews.com/us/news/trevi-therapeutics-q1-2026-earnings-haduvio-chronic-cough-updates 2026-07-01T14:56:48.905Z monthly 0.5 https://novapharmanews.com/us/news/soligenix-hybryte-phase-3-flash2-trial-interim-results-ctcl 2026-07-01T09:01:09.116Z monthly 0.5 https://novapharmanews.com/us/news/avicanna-us-cannabis-rescheduling-medical-research-development 2026-06-23T03:54:10.833Z monthly 0.5 https://novapharmanews.com/us/news/innocare-orelabrutinib-phase-3-trial-sle-treatment 2026-07-01T10:53:42.345Z monthly 0.5 https://novapharmanews.com/us/news/orca-bio-orca-q-fda-rmat-designation-blood-cancers 2026-07-01T03:14:48.029Z monthly 0.5 https://novapharmanews.com/us/news/formblends-2026-peptide-report-rfk-hhs-glp1-therapy-access 2026-06-29T20:23:25.949Z monthly 0.5 https://novapharmanews.com/us/news/c-ray-therapeutics-fda-copper-64-drug-master-file-approval 2026-07-01T19:31:40.393Z monthly 0.5 https://novapharmanews.com/us/news/brc-therapeutics-fda-clearance-brc-002-phase-1-trial-crps 2026-06-19T05:49:54.374Z monthly 0.5 https://novapharmanews.com/us/news/vanda-pharmaceuticals-imsidolimab-generalized-pustular-psoriasis-nejm-evidence 2026-07-01T19:18:47.830Z monthly 0.5 https://novapharmanews.com/us/news/astrazeneca-breztri-aerosphere-approved-first-triple-therapy-asthma-patients-12-older 2026-06-30T16:04:41.047Z monthly 0.5 https://novapharmanews.com/us/news/vensica-medical-fda-ind-approval-vixe-xeomin-needle-free-delivery-overactive-bladder 2026-07-01T09:18:07.187Z monthly 0.5 https://novapharmanews.com/us/news/abbvie-upadacitinib-rinvoq-fda-application-alopecia-areata 2026-07-01T11:56:03.979Z monthly 0.5 https://novapharmanews.com/us/news/novartis-q1-2026-earnings-remibrutinib-chmp-approval-pipeline-growth 2026-07-01T19:15:20.290Z monthly 0.5 https://novapharmanews.com/us/news/wave-life-sciences-wve-007-phase-2a-fda-approval-obesity-diabetes 2026-07-01T19:30:44.743Z monthly 0.5 https://novapharmanews.com/eu/news/biopharma-clinical-trials-daily-roundup 2026-07-01T05:17:32.688Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-emergent-evolveimmune-deals 2026-07-01T04:33:08.064Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-deal-surge-lilly-sun 2026-07-01T08:25:32.777Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-investment-trends 2026-06-30T03:01:04.049Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-annex-1-challenges 2026-06-30T21:58:55.692Z monthly 0.5 https://novapharmanews.com/us/news/cog-2024-day-1-highlights 2026-07-01T03:01:37.631Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-event-day-1 2026-06-25T01:20:06.144Z monthly 0.5 https://novapharmanews.com/us/news/ascrs-2026-opus-genetics-phentolamine-preview 2026-06-30T08:17:47.753Z monthly 0.5 https://novapharmanews.com/us/news/fdli-2026-fda-strategic-priorities 2026-06-30T18:58:50.283Z monthly 0.5 https://novapharmanews.com/us/news/cog-2024-day-1-roundup 2026-07-01T01:02:55.914Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-2026-daily-roundup 2026-06-26T06:00:00.104Z monthly 0.5 https://novapharmanews.com/apac/news/akso-health-group-brain-computer-interface-rd-program-neurotechnology 2026-07-01T04:10:45.524Z monthly 0.5 https://novapharmanews.com/apac/news/evofem-solosec-distribution-agreement-sub-saharan-africa 2026-06-19T07:17:33.189Z monthly 0.5 https://novapharmanews.com/apac/news/psg-2026-specialty-drug-benefits-report-cost-management-coverage-strategies 2026-07-01T15:46:09.718Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-apptec-q1-2026-revenue-growth-backlog-results 2026-07-01T15:58:39.114Z monthly 0.5 https://novapharmanews.com/apac/news/img-pharma-acquires-matsumoto-pharmaceutical-japan-expansion 2026-06-30T21:29:21.363Z monthly 0.5 https://novapharmanews.com/apac/news/aquestive-therapeutics-anaphylm-class-action-lawsuit-approval-timeline 2026-07-01T13:48:29.962Z monthly 0.5 https://novapharmanews.com/apac/news/biomarin-completes-amicus-therapeutics-acquisition-galafold-pompe-therapies 2026-07-01T12:42:11.121Z monthly 0.5 https://novapharmanews.com/eu/news/elanco-negasunt-tanidil-emergency-authorization-screwworm-livestock 2026-06-29T23:17:18.017Z monthly 0.5 https://novapharmanews.com/eu/news/opella-essentiale-excel-trial-fatty-liver-disease-masld-results 2026-07-01T09:03:53.195Z monthly 0.5 https://novapharmanews.com/eu/news/advanced-bifurcation-systems-acquires-svelte-medical-coronary-stent-deal 2026-06-30T18:48:06.902Z monthly 0.5 https://novapharmanews.com/eu/news/zentiva-appeals-eu-court-urban-wastewater-directive-generic-medicines 2026-07-01T09:22:34.609Z monthly 0.5 https://novapharmanews.com/eu/news/ab-science-loan-repayment-deferral-agreement-2026 2026-06-30T03:35:51.685Z monthly 0.5 https://novapharmanews.com/eu/news/mundipharma-rezzayo-rezafungin-phase-iii-respect-trial-results-fungal-disease-prevention 2026-07-01T14:33:07.249Z monthly 0.5 https://novapharmanews.com/eu/news/crinetics-palsonify-paltusotine-eu-approval-acromegaly-treatment 2026-07-01T08:34:43.529Z monthly 0.5 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0801-phase-2-aplastic-anemia-trial 2026-06-30T04:22:21.571Z monthly 0.5 https://novapharmanews.com/us/news/astrazeneca-saphnelo-autoinjector-fda-approved-lupus-self-administration 2026-07-01T11:54:29.908Z monthly 0.5 https://novapharmanews.com/us/news/dmx-200-action3-trial-statistical-power-blinded-review 2026-06-27T21:16:13.761Z monthly 0.5 https://novapharmanews.com/us/news/concept-medical-sirona-trial-3-year-data-charing-cross-2026 2026-06-30T21:26:54.538Z monthly 0.5 https://novapharmanews.com/us/news/intellia-lonvo-z-fda-submission-crispr-hereditary-angioedema 2026-07-01T15:41:13.190Z monthly 0.5 https://novapharmanews.com/us/news/cordis-selution-slr-drug-eluting-balloon-japan-launch-2026 2026-07-01T13:16:50.776Z monthly 0.5 https://novapharmanews.com/us/news/tovecimig-biliary-tract-cancer-trial-results-companion-002 2026-06-30T00:30:54.848Z monthly 0.5 https://novapharmanews.com/us/news/intellia-lonvoguran-ziclumeran-phase-3-hereditary-angioedema-gene-editing 2026-07-01T20:07:54.986Z monthly 0.5 https://novapharmanews.com/us/news/sagimet-biosciences-denifanstat-phase-3-acne-trial-2026 2026-07-01T19:30:39.716Z monthly 0.5 https://novapharmanews.com/us/news/apollomics-vebreltinib-phase-2-3-ind-submission-nsclc-treatment 2026-07-01T17:03:46.774Z monthly 0.5 https://novapharmanews.com/us/news/aclaris-therapeutics-ati-052-phase-1a-results-ati-2138-update-april-2026 2026-07-01T03:31:59.400Z monthly 0.5 https://novapharmanews.com/us/news/ose-immunotherapeutics-pegrizeprument-vel-101-fda-orphan-drug-designation-heart-transplant 2026-07-01T05:04:54.845Z monthly 0.5 https://novapharmanews.com/us/news/jazz-pharmaceuticals-ziihera-fda-priority-review-her2-cancer 2026-07-01T17:23:25.499Z monthly 0.5 https://novapharmanews.com/us/news/nccn-adds-nuvation-bio-taletrectinib-ibtrozi-cancer-guidelines-ros1-nsclc-brain-metastases 2026-07-01T04:24:19.097Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-imaavy-nipocalimab-warm-autoimmune-hemolytic-anemia 2026-07-01T08:00:05.648Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-caplyta-lumateperone-snda-schizophrenia-relapse-prevention 2026-07-01T04:35:42.007Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-pharma-news-roundup-april-28-2026 2026-07-01T09:02:31.785Z monthly 0.5 https://novapharmanews.com/us/news/4th-annual-cog-2026-no-pharma-news 2026-06-29T16:01:28.699Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-day-1-roundup 2026-07-01T15:30:52.696Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-patient-centric-trials-workforce 2026-07-01T12:59:54.345Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-regulatory-updates-day-1 2026-06-30T18:30:32.946Z monthly 0.5 https://novapharmanews.com/us/news/testosterone-therapy-fda-update-regulatory-advances 2026-07-01T13:40:24.086Z monthly 0.5 https://novapharmanews.com/us/news/glp-1-eating-disorder-risk-true-facts 2026-06-29T11:12:08.533Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-ai-pathology-oncolytic-virus 2026-06-30T19:21:40.395Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-phillips-medisize-sensing 2026-07-01T08:58:26.595Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-ai-patient-centricity 2026-07-01T05:27:42.805Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-2026-eu-biopharma-medtech-highlights 2026-07-01T16:02:32.657Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-funding-dealmaking-highlights 2026-07-01T09:27:47.037Z monthly 0.5 https://novapharmanews.com/eu/news/asco-2026-olverembatinib-gastric-cancer-trials 2026-07-01T07:54:38.499Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-sustainability-2026-packaging-preview 2026-07-01T04:04:04.715Z monthly 0.5 https://novapharmanews.com/apac/news/eyebright-medical-2025-annual-report-sustainability-results 2026-06-30T05:58:07.787Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-japanese-pharmacopoeia-medical-device-standards-regulatory-science 2026-07-01T09:53:13.578Z monthly 0.5 https://novapharmanews.com/eu/news/boston-scientific-securities-class-action-lawsuit-may-2026 2026-07-01T05:13:52.129Z monthly 0.5 https://novapharmanews.com/eu/news/brii-bio-elebsiran-hepatitis-b-control-apasl-2026-analysis 2026-06-30T08:01:55.945Z monthly 0.5 https://novapharmanews.com/us/news/ascletis-asc30-oral-glp-1-diabetes-phase-2-trial-enrollment-complete 2026-06-30T22:51:19.104Z monthly 0.5 https://novapharmanews.com/us/news/ascletis-asc30-phase-ii-enrollment-complete-oral-glp1-diabetes 2026-06-30T22:51:19.103Z monthly 0.5 https://novapharmanews.com/us/news/sun-pharma-acquires-organon-11-75-billion-merger-2026 2026-07-01T19:31:03.393Z monthly 0.5 https://novapharmanews.com/us/news/boston-scientific-farapulse-watchman-heart-rhythm-2026-data 2026-07-01T12:07:52.361Z monthly 0.5 https://novapharmanews.com/us/news/veradermics-vdphl01-phase-2-3-trial-results-male-pattern-hair-loss 2026-06-30T04:11:31.508Z monthly 0.5 https://novapharmanews.com/us/news/veradermics-vdphl01-phase-2-3-trial-results-conference-call 2026-06-29T19:51:20.647Z monthly 0.5 https://novapharmanews.com/us/news/adagio-medical-vclas-ventricular-ablation-system-pivotal-trial-results 2026-07-01T19:24:35.725Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-2026-opens 2026-06-30T07:53:51.764Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-daily-roundup 2026-06-29T20:31:45.522Z monthly 0.5 https://novapharmanews.com/apac/news/pmc-organometallix-price-increase-all-products-may-2026 2026-06-30T20:22:06.746Z monthly 0.5 https://novapharmanews.com/apac/news/tga-personalised-medical-device-regulations-guidance-2024 2026-06-30T20:46:39.639Z monthly 0.5 https://novapharmanews.com/us/news/atara-biotherapeutics-securities-class-action-lawsuit-may-2026-deadline 2026-07-01T06:37:10.930Z monthly 0.5 https://novapharmanews.com/us/news/aquestive-therapeutics-class-action-lawsuit-fda-application 2026-07-01T14:38:45.307Z monthly 0.5 https://novapharmanews.com/us/news/pulse-biosciences-npulse-cardiac-catheter-heart-rhythm-2026-trial-data 2026-06-30T20:01:04.553Z monthly 0.5 https://novapharmanews.com/us/news/abbott-tactiflex-duo-ablation-catheter-afib-results-hrs-2026 2026-07-01T10:19:55.494Z monthly 0.5 https://novapharmanews.com/us/news/medtronic-affera-sphere-9-catheter-fda-breakthrough-device-designation-ventricular-tachycardia 2026-07-01T09:10:23.382Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-rexatilux-ranibizumab-eye-treatment 2026-07-01T08:37:22.958Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-redemplo-plozasiran-european-approval 2026-07-01T18:26:38.721Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-viatris-palbociclib-generic-cancer-treatment 2026-07-01T13:54:31.809Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-itvisma-onasemnogene-abeparvovec-sma-gene-therapy 2026-07-01T13:31:56.745Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-cenrifki-tolebrutinib-multiple-sclerosis 2026-07-01T14:59:15.764Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approves-first-rna-veterinary-vaccine-nobivac-nxt-cats 2026-07-01T06:42:43.637Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approves-plozasiran-redemplo-familial-chylomicronaemia-syndrome-fcs 2026-07-01T18:42:01.617Z monthly 0.5 https://novapharmanews.com/eu/news/ema-chmp-recommends-tolebrutinib-cenrifki-five-medicines-approval-april-2026 2026-07-01T17:15:22.206Z monthly 0.5 https://novapharmanews.com/us/news/fda-gdufa-generic-drug-user-fee-amendments-2024-updates 2026-07-01T13:10:07.917Z monthly 0.5 https://novapharmanews.com/us/news/fda-omufa-user-fee-program-otc-monograph-drugs 2026-07-01T00:56:54.855Z monthly 0.5 https://novapharmanews.com/us/news/fda-gdufa-iv-reauthorization-2028-2032-generic-drug-user-fees 2026-07-01T10:08:42.108Z monthly 0.5 https://novapharmanews.com/us/news/fda-testosterone-therapy-low-libido-hypogonadism-2024 2026-06-30T21:01:49.610Z monthly 0.5 https://novapharmanews.com/us/news/fda-reduces-animal-testing-drug-development-alternatives-2024 2026-07-01T16:41:49.456Z monthly 0.5 https://novapharmanews.com/us/news/cms-fda-rapid-coverage-pathway-breakthrough-medical-devices-medicare 2026-07-01T14:22:13.550Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-otarmeni-first-gene-therapy-genetic-hearing-loss 2026-06-26T15:42:28.873Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerates-mental-health-treatment-access-executive-order 2026-07-01T07:18:07.223Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-day-1-roundup 2026-07-01T08:02:25.386Z monthly 0.5 https://novapharmanews.com/us/news/scope-x-2026-clinical-ops-data-ai-boston 2026-06-29T20:38:56.436Z monthly 0.5 https://novapharmanews.com/us/news/oct-east-coast-2026-clinical-trial-innovation 2026-07-01T19:38:02.001Z monthly 0.5 https://novapharmanews.com/apac/news/sunnybrook-41-million-investment-clinical-trials-canada 2026-07-01T02:53:47.081Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-biologics-chengdu-microbial-manufacturing-completion-2026 2026-07-01T17:35:27.250Z monthly 0.5 https://novapharmanews.com/apac/news/quasar-medical-thailand-manufacturing-facility-medtech-expansion 2026-07-01T01:01:31.711Z monthly 0.5 https://novapharmanews.com/apac/news/daewoong-nabota-master-class-prabotulinumtoxina-safety-2026 2026-07-01T16:47:13.687Z monthly 0.5 https://novapharmanews.com/apac/news/amcor-35m-healthcare-packaging-facility-malaysia-medical-supply-chain 2026-07-01T03:59:44.284Z monthly 0.5 https://novapharmanews.com/apac/news/transcarent-smithrx-partnership-pharmacy-benefits-platform 2026-06-30T04:26:21.527Z monthly 0.5 https://novapharmanews.com/apac/news/hanchorbio-bloomberg-partnership-drug-development-intelligence 2026-06-29T22:04:01.052Z monthly 0.5 https://novapharmanews.com/eu/news/aetna-prior-authorization-reform-88-percent-standardized-2026 2026-06-22T11:25:34.711Z monthly 0.5 https://novapharmanews.com/eu/news/guerbet-lipiodol-ultra-fluid-eu-approval-vascular-embolization 2026-06-30T22:04:11.563Z monthly 0.5 https://novapharmanews.com/eu/news/rna-therapy-clinical-trials-market-3-4-billion-2035-forecast 2026-06-30T02:17:05.395Z monthly 0.5 https://novapharmanews.com/eu/news/oncotelic-therapeutics-partnership-strategy-update-2026 2026-07-01T15:04:08.727Z monthly 0.5 https://novapharmanews.com/eu/news/clinuvel-scenesse-phase-iii-vitiligo-trial-ema-approval-2026 2026-06-30T16:16:55.103Z monthly 0.5 https://novapharmanews.com/us/news/frankfurt-court-upholds-besremi-arbitral-award-aop-health-pharmaessentia 2026-07-01T06:30:47.233Z monthly 0.5 https://novapharmanews.com/us/news/novartis-coartem-baby-who-prequalification-malaria-treatment-newborns 2026-07-01T12:25:43.533Z monthly 0.5 https://novapharmanews.com/us/news/miracell-smart-m-cell-alzheimers-stem-cell-therapy-results 2026-06-30T08:12:08.099Z monthly 0.5 https://novapharmanews.com/us/news/berlin-heals-positive-cmic-iii-heart-failure-device-results 2026-06-30T23:33:14.355Z monthly 0.5 https://novapharmanews.com/us/news/citius-pharmaceuticals-5-million-direct-offering-stock-nasdaq 2026-06-30T19:29:54.405Z monthly 0.5 https://novapharmanews.com/us/news/haemonetics-vascade-mvp-xl-safety-efficacy-study-large-bore-venous-closure 2026-07-01T10:30:59.399Z monthly 0.5 https://novapharmanews.com/us/news/briohealth-solutions-fda-approval-pediatric-briovad-heart-device-trial 2026-07-01T17:47:50.634Z monthly 0.5 https://novapharmanews.com/us/news/cgbio-fda-clearance-easymade-ti-titanium-implant 2026-06-30T20:28:43.025Z monthly 0.5 https://novapharmanews.com/us/news/cerapedics-vizient-supplier-agreement-pearlmatrix-p15-bone-graft 2026-07-01T19:08:41.363Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-day-1 2026-07-01T15:20:30.301Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-daily-roundup 2026-06-23T16:00:48.692Z monthly 0.5 https://novapharmanews.com/apac/news/catalym-visugromab-phase-2-3-trial-cancer-cachexia-first-patient-dosed 2026-06-30T15:35:06.922Z monthly 0.5 https://novapharmanews.com/apac/news/spinogenix-spg601-clarity-trial-fragile-x-syndrome-phase-2b-3 2026-07-01T10:03:18.510Z monthly 0.5 https://novapharmanews.com/apac/news/tga-biologicals-regulatory-framework-advanced-therapies-australia 2026-07-01T05:04:55.869Z monthly 0.5 https://novapharmanews.com/eu/news/renovorx-tamp-therapy-asco-2026-tiger-pac-trial-data 2026-07-01T04:33:57.297Z monthly 0.5 https://novapharmanews.com/eu/news/genomics-services-market-24-billion-2033-precision-medicine 2026-07-01T02:01:14.814Z monthly 0.5 https://novapharmanews.com/eu/news/accenture-invests-iridius-ai-compliance-life-sciences 2026-07-01T12:42:10.612Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-q1-2026-sales-growth-momentum 2026-07-01T09:58:01.491Z monthly 0.5 https://novapharmanews.com/eu/news/cumberland-pharmaceuticals-apotex-strategic-integration-partnership 2026-07-01T19:02:57.057Z monthly 0.5 https://novapharmanews.com/us/news/cortec-brain-interchange-bci-fda-tap-program-stroke-rehabilitation 2026-07-01T15:27:43.193Z monthly 0.5 https://novapharmanews.com/us/news/tivic-health-rebrands-valion-bio-entolimod-acute-radiation-syndrome-fda-fast-track 2026-07-01T04:23:30.849Z monthly 0.5 https://novapharmanews.com/us/news/edwards-lifesciences-q1-2026-results-tmtt-sales-guidance-raise 2026-07-01T14:56:08.573Z monthly 0.5 https://novapharmanews.com/us/news/immunitybio-ibrx-fda-warning-letter-class-action-lawsuit-anktiva 2026-07-01T16:55:29.473Z monthly 0.5 https://novapharmanews.com/us/news/transmedics-chops-organ-preservation-system-ishlt-2026 2026-06-30T23:24:19.308Z monthly 0.5 https://novapharmanews.com/us/news/abbvie-fda-complete-response-letter-trenibotulinumtoxine-trenibote-manufacturing 2026-06-29T16:45:45.169Z monthly 0.5 https://novapharmanews.com/us/news/alpha-tau-fda-approval-alpha-dart-pancreatic-cancer-trial-expansion 2026-07-01T07:19:26.606Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-regeneron-otarmeni-gene-therapy-genetic-hearing-loss 2026-07-01T18:19:48.998Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-parexel-hiring 2026-07-01T00:44:51.268Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-day1-roundup 2026-06-30T21:14:06.934Z monthly 0.5 https://novapharmanews.com/us/news/generic-drug-forum-2026-highlights 2026-07-01T16:48:05.035Z monthly 0.5 https://novapharmanews.com/eu/news/tilray-brands-us-medical-cannabis-expansion-rescheduling-2026 2026-07-01T01:09:49.135Z monthly 0.5 https://novapharmanews.com/us/news/capricor-therapeutics-hope-3-phase-3-deramiocel-duchenne-muscular-dystrophy-aan-2026 2026-07-01T19:11:27.347Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-event-pharma-ai-future 2026-07-01T05:12:16.572Z monthly 0.5 https://novapharmanews.com/apac/news/samsung-bioepis-sbe303-phase-1-trial-sandoz-partnership-2026 2026-07-01T17:44:56.807Z monthly 0.5 https://novapharmanews.com/apac/news/fosun-health-wins-awards-globalhealth-asia-pacific-forum-2026 2026-07-01T01:36:37.681Z monthly 0.5 https://novapharmanews.com/apac/news/minjuvi-tafasitamab-approved-australia-follicular-lymphoma 2026-07-01T14:07:21.041Z monthly 0.5 https://novapharmanews.com/eu/news/ccbd-car-t-cell-therapy-maryland-community-oncology 2026-07-01T18:06:20.572Z monthly 0.5 https://novapharmanews.com/eu/news/samacare-prior-authorization-benchmarks-medical-benefit-drugs 2026-06-30T10:16:31.079Z monthly 0.5 https://novapharmanews.com/eu/news/repertoire-immune-medicines-rptr-1-201-phase-1-2-trial-advanced-solid-tumors 2026-07-01T13:05:07.315Z monthly 0.5 https://novapharmanews.com/eu/news/alpha-tau-alpha-dart-pancreatic-cancer-acapella-trial-first-patient 2026-07-01T10:41:55.025Z monthly 0.5 https://novapharmanews.com/eu/news/alpha-tau-alpha-dart-pancreatic-cancer-acapella-trial-europe 2026-06-30T00:54:15.808Z monthly 0.5 https://novapharmanews.com/eu/news/blinatumomab-pediatric-leukemia-safety-study-final-stage 2026-06-29T17:10:24.426Z monthly 0.5 https://novapharmanews.com/eu/news/healthcare-third-party-logistics-market-growth-502-billion-2034 2026-06-30T04:13:31.596Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-intermediates-market-57-billion-2035-generic-drugs 2026-06-30T21:34:53.141Z monthly 0.5 https://novapharmanews.com/us/news/ose-immunotherapeutics-tedopi-ovarian-cancer-asco-2026-presentation 2026-07-01T05:15:19.895Z monthly 0.5 https://novapharmanews.com/us/news/nectero-therapeutics-east-system-two-year-safety-data-abdominal-aortic-aneurysm 2026-07-01T11:29:44.111Z monthly 0.5 https://novapharmanews.com/us/news/novo-nordisk-oral-semaglutide-children-type-2-diabetes-pioneer-teens-trial 2026-07-01T13:54:27.802Z monthly 0.5 https://novapharmanews.com/us/news/greenwich-lifesciences-glsi-100-asco-2026-breast-cancer-immunotherapy 2026-07-01T12:45:55.549Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-9mw2821-nectin-4-adc-phase-iii-triple-negative-breast-cancer 2026-07-01T00:22:48.622Z monthly 0.5 https://novapharmanews.com/us/news/clearpoint-neuro-fda-clearance-velocity-alpha-surgical-drill-system 2026-06-25T22:48:26.662Z monthly 0.5 https://novapharmanews.com/us/news/vistagen-refisolone-fda-approval-menopause-hot-flashes-phase-2-trial 2026-07-01T16:53:54.427Z monthly 0.5 https://novapharmanews.com/us/news/avai-bio-fda-cellular-rejuvenation-trial-anti-aging-market-120-billion 2026-06-30T21:44:02.407Z monthly 0.5 https://novapharmanews.com/us/news/cipla-fda-approval-first-generic-ventolin-hfa-albuterol-sulfate 2026-07-01T13:11:23.200Z monthly 0.5 https://novapharmanews.com/us/news/dupixent-approved-chronic-spontaneous-urticaria-children-sanofi 2026-07-01T05:15:01.535Z monthly 0.5 https://novapharmanews.com/us/news/oncology-data-trends-2026-preview 2026-07-01T18:33:17.080Z monthly 0.5 https://novapharmanews.com/us/news/redi-2026-fda-regulatory-strategies-conference-preview 2026-07-01T13:09:48.447Z monthly 0.5 https://novapharmanews.com/us/news/bionj-biopartnering-conference-2026-preview 2026-07-01T17:08:02.851Z monthly 0.5 https://novapharmanews.com/us/news/fierce-biotech-week-2026-boston-preview 2026-07-01T14:34:14.001Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-day-1-eu-takeaways 2026-06-30T18:30:28.494Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2026-ai-biotech-preview 2026-07-01T09:29:40.165Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-day-1-roundup 2026-06-29T21:11:01.858Z monthly 0.5 https://novapharmanews.com/us/news/oct-east-coast-2026-cro-trends-outsourcing 2026-07-01T15:20:33.721Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-biotech-day-1-roundup 2026-07-01T00:57:25.820Z monthly 0.5 https://novapharmanews.com/apac/news/calluna-pharma-cal101-phase-2-enrollment-ipf-treatment 2026-07-01T15:07:06.667Z monthly 0.5 https://novapharmanews.com/apac/news/anixa-biosciences-lira-cel-car-t-ovarian-cancer-survival-data 2026-07-01T11:51:28.841Z monthly 0.5 https://novapharmanews.com/apac/news/hengrui-pharma-q1-2026-anti-pd-l1-tgf-beta-fusion-protein-approved-china 2026-07-01T15:31:27.921Z monthly 0.5 https://novapharmanews.com/apac/news/sonorous-neurovascular-fda-clearance-boscath-catheter-2026 2026-07-01T14:57:23.977Z monthly 0.5 https://novapharmanews.com/apac/news/alphamab-oncology-jskn016-trop2-her3-bispecific-adc-her2-negative-breast-cancer-asco-2026 2026-07-01T03:45:18.430Z monthly 0.5 https://novapharmanews.com/apac/news/rfid-technology-pharmaceutical-supply-chain-15-billion-2032 2026-06-30T23:02:35.255Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-biologics-south-korea-gmp-certification-bispecific-antibody-manufacturing 2026-06-30T20:47:58.205Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-therapeutic-sunscreen-regulatory-framework-2024 2026-07-01T10:59:38.528Z monthly 0.5 https://novapharmanews.com/eu/news/belite-bio-tinlarebant-nda-submission-stargardt-disease-phase-3-dragon-trial 2026-07-01T12:42:10.279Z monthly 0.5 https://novapharmanews.com/eu/news/abivax-obefazimod-phase-3-data-digestive-disease-week-2026 2026-07-01T19:06:32.203Z monthly 0.5 https://novapharmanews.com/eu/news/pet-service-holding-2025-annual-results-veterinary-regulatory-changes 2026-06-29T21:10:22.591Z monthly 0.5 https://novapharmanews.com/eu/news/femasys-femaseed-complete-fertility-solution-obgyn-acog-2026 2026-07-01T08:49:34.635Z monthly 0.5 https://novapharmanews.com/eu/news/mauna-kea-technologies-ce-mark-mdr-approval-european-expansion 2026-07-01T12:04:56.427Z monthly 0.5 https://novapharmanews.com/eu/news/pembrolizumab-lenvatinib-clear-cell-cancer-trial-results 2026-06-30T20:27:43.297Z monthly 0.5 https://novapharmanews.com/eu/news/roche-gazyva-fda-acceptance-lupus-treatment-phase-iii-allegory 2026-06-30T18:25:35.315Z monthly 0.5 https://novapharmanews.com/eu/news/ipsen-ojemda-tovorafenib-eu-approval-pediatric-brain-cancer-braf 2026-07-01T06:47:49.501Z monthly 0.5 https://novapharmanews.com/us/news/alterity-ath434-multiple-system-atrophy-phase-2-results 2026-06-30T23:17:21.076Z monthly 0.5 https://novapharmanews.com/us/news/tempest-therapeutics-tpst-2003-car-t-manufacturing-milestone-2026 2026-07-01T08:29:11.724Z monthly 0.5 https://novapharmanews.com/us/news/phanes-therapeutics-spevatamig-phase-2-results-pancreatic-cancer-asco-2026 2026-07-01T02:32:45.936Z monthly 0.5 https://novapharmanews.com/us/news/netris-pharma-np137-pancreatic-cancer-phase-1b-nature-results 2026-07-01T14:18:12.959Z monthly 0.5 https://novapharmanews.com/us/news/neurosterix-ntx-253-phase-1-schizophrenia-trial-q2-2026 2026-07-01T16:13:00.490Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-9mw2821-toripalimab-asco-2026-urothelial-carcinoma 2026-07-01T03:30:09.047Z monthly 0.5 https://novapharmanews.com/us/news/fda-complete-response-letter-atara-biotherapeutics-ebvallo-tabelecleucel-securities-lawsuit 2026-07-01T15:48:23.152Z monthly 0.5 https://novapharmanews.com/us/news/immunitybio-ibrx-securities-lawsuit-fda-warning-letter-cancer-claims 2026-06-29T17:11:52.331Z monthly 0.5 https://novapharmanews.com/us/news/labcorp-fda-approved-pd-l1-companion-diagnostic-keytruda-ovarian-cancer 2026-07-01T12:51:10.363Z monthly 0.5 https://novapharmanews.com/us/news/dupixent-approved-children-chronic-spontaneous-urticaria-csu 2026-07-01T16:30:49.023Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-daily-roundup 2026-07-01T15:07:44.104Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-day-1-highlights 2026-07-01T06:15:07.367Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-news-today-opioid-crisis-drug-pricing-supply-chain 2026-06-30T16:56:47.547Z monthly 0.5 https://novapharmanews.com/eu/news/fda-idvynso-ascentage-asco-2026 2026-07-01T08:40:27.881Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-oncology-highlights 2026-07-01T15:47:50.516Z monthly 0.5 https://novapharmanews.com/apac/news/kelun-biotech-sacituzumab-tirumotecan-asco-2026-presentations 2026-06-28T13:01:55.658Z monthly 0.5 https://novapharmanews.com/apac/news/novi-health-glp-1-hybrid-care-model-clinical-real-world-gap 2026-06-30T19:45:44.436Z monthly 0.5 https://novapharmanews.com/apac/news/duchesnay-peripharm-regulatory-reform-womens-health-access-canada 2026-06-30T05:15:44.836Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-updates-ivd-regulations-medical-device-manufacturers 2026-07-01T07:30:50.264Z monthly 0.5 https://novapharmanews.com/apac/news/washington-state-life-sciences-industry-growth-2024 2026-06-30T16:51:53.529Z monthly 0.5 https://novapharmanews.com/eu/news/redhill-opaganib-neuroblastoma-breast-cancer-aacr-2026 2026-07-01T09:05:24.635Z monthly 0.5 https://novapharmanews.com/eu/news/sab-biotherapeutics-sab-142-c-peptide-preservation-type-1-diabetes-phase-1-trial 2026-07-01T07:47:13.581Z monthly 0.5 https://novapharmanews.com/eu/news/boston-scientific-q1-2026-earnings-clinical-trial-results 2026-07-01T04:52:36.930Z monthly 0.5 https://novapharmanews.com/eu/news/cervomed-neflamapimod-brain-volume-increase-dementia-lewy-bodies-aan-2026 2026-07-01T05:32:41.873Z monthly 0.5 https://novapharmanews.com/eu/news/celerion-thl-partners-majority-investment-clinical-research 2026-07-01T07:53:35.766Z monthly 0.5 https://novapharmanews.com/eu/news/veristat-acquires-certara-regulatory-writing-business-european-expansion 2026-07-01T13:18:28.713Z monthly 0.5 https://novapharmanews.com/eu/news/lung-cancer-therapeutics-market-142-billion-precision-medicine-2036 2026-07-01T08:56:06.639Z monthly 0.5 https://novapharmanews.com/eu/news/drug-delivery-devices-market-growth-forecast-2032-biologics 2026-07-01T06:24:34.539Z monthly 0.5 https://novapharmanews.com/eu/news/polycythemia-vera-market-transformation-protagonist-therapeutics-rusfertide-2036 2026-07-01T16:58:43.681Z monthly 0.5 https://novapharmanews.com/eu/news/ipsen-ojemda-tovorafenib-first-targeted-therapy-pediatric-brain-tumors-eu-approval 2026-07-01T06:47:49.499Z monthly 0.5 https://novapharmanews.com/us/news/denali-therapeutics-fda-approval-avlayah-tividenofusp-alfa-hunter-syndrome 2026-07-01T20:08:01.811Z monthly 0.5 https://novapharmanews.com/us/news/pfizer-lorbrena-braftovi-asco-2026-cancer-trials 2026-07-01T18:37:57.910Z monthly 0.5 https://novapharmanews.com/us/news/boston-scientific-q1-2026-earnings-results-revenue-growth 2026-07-01T17:50:53.121Z monthly 0.5 https://novapharmanews.com/us/news/ractigen-rag-17-als-phase-1-trial-results-2026 2026-07-01T07:56:36.687Z monthly 0.5 https://novapharmanews.com/us/news/avacta-ava6103-cancer-drug-aacr-2026-data-enhertu-comparison 2026-06-26T12:52:01.445Z monthly 0.5 https://novapharmanews.com/us/news/innovent-ibi363-clinical-data-asco-2026 2026-06-30T21:42:42.603Z monthly 0.5 https://novapharmanews.com/us/news/fda-extends-sanofi-sarclisa-subcutaneous-review-multiple-myeloma 2026-06-30T21:45:49.187Z monthly 0.5 https://novapharmanews.com/us/news/nrx-pharmaceuticals-fda-feedback-preservative-free-ketamine-generic 2026-06-29T21:15:22.791Z monthly 0.5 https://novapharmanews.com/us/news/lupin-launches-generic-dapagliflozin-metformin-xr-tablets-us-xigduo-alternative 2026-07-01T07:56:59.127Z monthly 0.5 https://novapharmanews.com/us/news/sanofi-tzield-fda-approval-children-type-1-diabetes-delay 2026-07-01T15:14:35.974Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-sanofi-tzield-children-type-1-diabetes-delay 2026-07-01T06:51:22.599Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-2026-eu-day-1-roundup 2026-06-30T19:04:02.128Z monthly 0.5 https://novapharmanews.com/us/news/generic-drug-forum-us-market-access 2026-07-01T17:21:50.392Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-biotech-innovations-day-1 2026-07-01T07:18:59.317Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2024-daily-oncology-research-roundup 2026-06-30T20:12:11.347Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-news-purdue-sentencing-supply-chain-asco 2026-06-30T23:13:17.616Z monthly 0.5 https://novapharmanews.com/us/news/generic-drugs-forum-2026-fda-event-opens 2026-06-30T13:39:22.890Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-avantor-biolife-aes-highlights 2026-07-01T09:33:10.914Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2024-oncology-news-day-1 2026-06-30T07:33:06.508Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2024-oncology-research-highlights-day-1 2026-06-29T02:10:24.010Z monthly 0.5 https://novapharmanews.com/eu/news/slas-europe-2026-lab-automation-screening 2026-07-01T19:29:24.790Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-partnering-eu-2026-biotech-bdl-preview 2026-06-30T16:31:04.123Z monthly 0.5 https://novapharmanews.com/us/news/fda-redi-conference-2026-preview 2026-06-15T19:57:27.503Z monthly 0.5 https://novapharmanews.com/us/news/scopex-2026-causal-ai-ml-clinical-trials-preview 2026-06-30T15:00:25.893Z monthly 0.5 https://novapharmanews.com/us/news/pharma-manufacturing-innovation-us-2026 2026-06-29T20:08:03.567Z monthly 0.5 https://novapharmanews.com/eu/news/eu-pharma-innovation-trends-2026 2026-06-30T17:22:24.496Z monthly 0.5 https://novapharmanews.com/us/news/ispor-2026-cardiology-heor-preview 2026-07-01T05:52:09.284Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-2026-biotech-preview 2026-06-30T05:22:59.696Z monthly 0.5 https://novapharmanews.com/us/news/bio-it-world-2026-ai-oncology-preview 2026-07-01T01:06:01.054Z monthly 0.5 https://novapharmanews.com/us/news/ispor-2026-heor-policy-pharma-pricing 2026-07-01T16:13:34.511Z monthly 0.5 https://novapharmanews.com/us/news/2nd-annual-cog-2026-pharma-preview 2026-06-30T20:31:05.578Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2026-preview 2026-07-01T00:49:46.423Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-calidi-biotherapeutics-redtail-preview 2026-06-30T18:53:46.583Z monthly 0.5 https://novapharmanews.com/apac/news/pda-apac-pharma-manufacturing-trends-2026 2026-07-01T20:03:11.386Z monthly 0.5 https://novapharmanews.com/eu/news/isct-2026-cell-gene-therapy-manufacturing-dublin 2026-06-29T11:01:43.750Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-gene-therapy-preview 2026-07-01T18:47:25.136Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-gene-therapy-manufacturing-preview 2026-07-01T01:02:50.526Z monthly 0.5 https://novapharmanews.com/us/news/thma-cpe-circle-2026-pharma-exec-networking 2026-06-27T19:04:25.093Z monthly 0.5 https://novapharmanews.com/us/news/thma-oncology-forum-2026-pharma-insights 2026-07-01T04:58:49.510Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-2026-eu-mdr-regulatory-tech 2026-07-01T12:23:00.144Z monthly 0.5 https://novapharmanews.com/eu/news/european-research-revolution-clinical-trial-tech 2026-06-30T01:53:10.115Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-preview 2026-07-01T12:20:00.929Z monthly 0.5 https://novapharmanews.com/eu/news/swiss-biotech-day-2026-preview 2026-07-01T16:35:43.489Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-2026-preview 2026-07-01T14:12:21.778Z monthly 0.5 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-oncology-asco-aua 2026-06-30T15:08:18.823Z monthly 0.5 https://novapharmanews.com/us/news/4th-annual-cog-preview 2026-06-29T23:00:01.957Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-2026-apac-biotech-preview 2026-07-01T19:59:13.737Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-2026-preview 2026-07-01T15:52:40.163Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-pembrolizumab-bowel-cancer-moderna-melanoma 2026-07-01T12:57:16.917Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-day3-immunotherapy-kras-mrna 2026-07-01T01:53:27.653Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-preview 2026-06-19T10:50:19.552Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-2024-preview-eu 2026-07-01T15:20:44.415Z monthly 0.5 https://novapharmanews.com/apac/news/suvoda-agentic-ai-rtsm-clinical-trial-startup-reduction 2026-07-01T18:38:42.595Z monthly 0.5 https://novapharmanews.com/apac/news/dayspring-pharma-cg2001-foam-phase-ii-trial-androgenetic-alopecia-results 2026-06-30T08:06:02.143Z monthly 0.5 https://novapharmanews.com/apac/news/myome-board-appointments-healthcare-leaders-ai-genomics 2026-07-01T12:18:57.942Z monthly 0.5 https://novapharmanews.com/apac/news/synbiotech-l-plantarum-fs4722-hyperuricemia-prevention-preclinical 2026-06-30T10:24:54.027Z monthly 0.5 https://novapharmanews.com/apac/news/nasal-sprays-market-29-billion-2036-allergy-growth 2026-06-30T16:23:50.588Z monthly 0.5 https://novapharmanews.com/apac/news/andelyn-biosciences-encell-gene-therapy-manufacturing-partnership 2026-06-30T22:54:41.567Z monthly 0.5 https://novapharmanews.com/apac/news/turbine-crown-bioscience-ai-organoid-cancer-drug-discovery-partnership 2026-07-01T01:13:44.734Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-medicinal-cannabis-pediatric-access-guidelines-2024 2026-07-01T06:50:37.859Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-unapproved-therapeutic-goods-special-access-scheme-guidance 2026-07-01T01:22:54.081Z monthly 0.5 https://novapharmanews.com/apac/news/ghit-fund-8-5-million-malaria-ntd-drug-development-gsk-eisai 2026-06-30T00:07:57.023Z monthly 0.5 https://novapharmanews.com/eu/news/kelun-biotech-sac-tmt-asco-2026-presentations 2026-07-01T03:45:26.768Z monthly 0.5 https://novapharmanews.com/eu/news/prescriberpoint-ai-prior-authorization-platform-clinician-acceptance-rate 2026-07-01T20:03:45.971Z monthly 0.5 https://novapharmanews.com/eu/news/grail-galleri-cancer-detection-asco-2026-results 2026-07-01T18:39:37.171Z monthly 0.5 https://novapharmanews.com/eu/news/eupraxia-pharmaceuticals-positive-resolve-trial-eosinophilic-esophagitis-data 2026-07-01T13:02:27.342Z monthly 0.5 https://novapharmanews.com/eu/news/cellcarta-regask-ai-platform-regulatory-compliance-efficiency 2026-07-01T17:06:41.939Z monthly 0.5 https://novapharmanews.com/eu/news/leerink-partners-medincell-outperform-uzedy-risperidone-lai-fda-approval 2026-07-01T18:47:22.448Z monthly 0.5 https://novapharmanews.com/eu/news/getinge-cardiohelp-ii-ce-mark-intergard-synergy-eu-mdr-approval 2026-07-01T16:21:31.438Z monthly 0.5 https://novapharmanews.com/eu/news/karyopharm-phase-3-sentry-trial-asco-2026-myelofibrosis 2026-07-01T14:43:16.143Z monthly 0.5 https://novapharmanews.com/eu/news/allogene-therapeutics-expands-cemacabtagene-ansegedleucel-alpha3-trial-south-korea-australia 2026-06-30T23:30:41.072Z monthly 0.5 https://novapharmanews.com/eu/news/biocon-health-canada-approval-denosumab-biosimilars-bosaya-vevzuo 2026-07-01T06:19:19.338Z monthly 0.5 https://novapharmanews.com/us/news/francis-medical-vanquish-prostate-ablation-midwest-first-procedure 2026-06-30T20:28:43.084Z monthly 0.5 https://novapharmanews.com/us/news/aquestive-therapeutics-anaphylm-fda-deficiencies-class-action-lawsuit 2026-06-30T01:01:45.139Z monthly 0.5 https://novapharmanews.com/us/news/efemoral-medical-bioresorbable-scaffold-97-percent-patency-peripheral-artery-disease 2026-06-28T17:39:48.855Z monthly 0.5 https://novapharmanews.com/us/news/kyverna-miv-cel-stiff-person-syndrome-trial-results-breakthrough 2026-07-01T20:01:09.439Z monthly 0.5 https://novapharmanews.com/us/news/invera-medical-90-percent-vein-closure-chronic-venous-disease-trial-results 2026-06-30T14:10:22.265Z monthly 0.5 https://novapharmanews.com/us/news/reva-medical-motiv-scaffold-superior-results-critical-limb-ischemia-trial 2026-06-30T04:22:38.004Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-nectin-4-adc-bulumtatug-fuvedotin-cervical-cancer-nejm-case-report 2026-07-01T20:10:15.756Z monthly 0.5 https://novapharmanews.com/us/news/outlook-therapeutics-fda-dispute-resolution-lytenava-bevacizumab 2026-07-01T05:59:16.538Z monthly 0.5 https://novapharmanews.com/us/news/follicular-lymphoma-clinical-trials-45-companies-2026 2026-07-01T16:32:49.092Z monthly 0.5 https://novapharmanews.com/us/news/obsidian-therapeutics-obx-115-phase-2-melanoma-asco-2026 2026-07-01T15:55:28.527Z monthly 0.5 https://novapharmanews.com/us/news/icecure-medical-prosense-revenue-increases-30-percent-q1-2026 2026-07-01T17:15:50.010Z monthly 0.5 https://novapharmanews.com/us/news/nuvalent-neladalkib-alkove-1-trial-data-asco-2026-alk-positive-nsclc 2026-07-01T15:37:31.277Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-merck-idvynso-hiv-treatment-doravirine-islatravir 2026-07-01T14:35:21.176Z monthly 0.5 https://novapharmanews.com/apac/news/peptidream-asahi-kasei-ak1940-phase-1-clinical-trial 2026-06-30T10:36:26.018Z monthly 0.5 https://novapharmanews.com/apac/news/rznomics-rz-001-hepatocellular-carcinoma-trial-results-aacr-2026 2026-07-01T18:01:27.704Z monthly 0.5 https://novapharmanews.com/apac/news/biogen-acquires-felzartamab-tj-biopharma-china 2026-07-01T18:32:58.746Z monthly 0.5 https://novapharmanews.com/apac/news/argo-biopharma-bw-40202-phase-ii-trials-sirna-therapy 2026-07-01T13:06:31.118Z monthly 0.5 https://novapharmanews.com/apac/news/mabwell-bioscience-pics-gmp-inspection-denosumab-biosimilars-jordan 2026-06-30T20:14:05.581Z monthly 0.5 https://novapharmanews.com/apac/news/mabwell-t-mab-jordan-gmp-inspection-denosumab-biosimilars-approval 2026-07-01T19:54:07.677Z monthly 0.5 https://novapharmanews.com/apac/news/quality-executive-partners-vienni-virtuosi-india-pharmaceutical-training 2026-06-30T23:48:22.235Z monthly 0.5 https://novapharmanews.com/apac/news/synsmart-amporin-partnership-small-molecule-therapeutics-degenerative-diseases 2026-07-01T08:54:26.309Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-otc-medicine-registration-guidelines-update 2026-06-26T06:38:09.200Z monthly 0.5 https://novapharmanews.com/apac/news/methylphenidate-shortage-update-concerta-ritalin-rubifen-supply-2026 2026-07-01T07:38:07.838Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-approves-peripheral-rotablator-pro-visual-ice-cryoablation-system-japan 2026-06-28T07:47:52.209Z monthly 0.5 https://novapharmanews.com/eu/news/cigna-healthcare-imuldosa-biosimilar-preferred-coverage-accord-biopharma 2026-06-30T15:44:12.161Z monthly 0.5 https://novapharmanews.com/eu/news/briacell-bria-ots-phase-3-breast-cancer-quality-life-aacr-2026 2026-07-01T16:12:58.334Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-isolators-market-782-billion-eu-gmp-annex-1 2026-06-30T02:01:52.611Z monthly 0.5 https://novapharmanews.com/eu/news/mabwell-pics-gmp-compliance-jordan-fda-biopharmaceutical-manufacturing 2026-06-29T17:44:49.747Z monthly 0.5 https://novapharmanews.com/eu/news/implantica-refluxstop-device-safety-study-602-patients-europe 2026-07-01T02:15:41.436Z monthly 0.5 https://novapharmanews.com/eu/news/askbio-ametefgene-parvec-phase-ii-parkinson-gene-therapy 2026-06-30T12:33:09.904Z monthly 0.5 https://novapharmanews.com/us/news/lenz-therapeutics-vizz-presbyopia-uk-mhra-approval-submission 2026-07-01T00:28:22.521Z monthly 0.5 https://novapharmanews.com/us/news/pasithea-pas-004-fda-rare-pediatric-disease-designation-nf1 2026-06-30T18:33:22.818Z monthly 0.5 https://novapharmanews.com/us/news/clearmind-medicine-cmnd-100-safety-endpoint-alcohol-use-disorder-trial 2026-07-01T13:04:49.821Z monthly 0.5 https://novapharmanews.com/us/news/sapience-therapeutics-st316-phase-2-colorectal-cancer-results 2026-07-01T19:01:21.707Z monthly 0.5 https://novapharmanews.com/us/news/tozorakimab-phase-3-miranda-trial-copd-exacerbations-reduction 2026-07-01T02:19:31.565Z monthly 0.5 https://novapharmanews.com/us/news/abogen-abo2203-mrna-cancer-therapy-b-cell-lymphoma-trial-aacr-2026 2026-07-01T17:37:18.230Z monthly 0.5 https://novapharmanews.com/us/news/verismo-synkir-110-phase-1-trial-results-aacr-2026 2026-07-01T09:46:46.878Z monthly 0.5 https://novapharmanews.com/us/news/inhibrx-ozekibart-inbrx-109-colorectal-cancer-clinical-update-webcast 2026-06-30T18:28:16.629Z monthly 0.5 https://novapharmanews.com/us/news/akeso-cadonilimab-pancreatic-cancer-phase-2-trial-results 2026-06-30T22:46:20.680Z monthly 0.5 https://novapharmanews.com/us/news/debiopharm-lunresertib-fda-fast-track-ovarian-cancer 2026-07-01T16:17:04.106Z monthly 0.5 https://novapharmanews.com/us/news/adcendo-adce-t02-expansion-phase-adce-d01-fda-orphan-drug-designation 2026-07-01T05:06:13.880Z monthly 0.5 https://novapharmanews.com/us/news/fda-accepts-genentech-gazyva-lupus-treatment-application 2026-07-01T15:34:01.916Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-padcev-keytruda-bladder-cancer-astellas 2026-07-01T13:46:47.885Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-dermaclear-severe-acne-2026 2026-06-30T10:37:23.416Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cell-therapy-multiple-sclerosis-2024 2026-06-30T18:17:00.010Z monthly 0.5 https://novapharmanews.com/us/news/fda-biosimilar-substitution-policy-update-2024 2026-07-01T12:18:01.306Z monthly 0.5 https://novapharmanews.com/eu/news/ema-biosimilar-policy-impact-2024 2026-07-01T14:56:52.596Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-paxlovid-covid19-treatment-eua-2024 2026-06-28T01:03:33.744Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-riabni-rituximab-biosimilar-nhl-2024 2026-06-30T17:38:39.510Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-adagrasib-kras-g12c-nsclc-2024 2026-07-01T19:05:45.562Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-apretude-injectable-prep-hiv-2024 2026-07-01T04:35:54.766Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-skin-renew-new-indication-severe-eczema-2024 2026-06-29T08:36:44.120Z monthly 0.5 https://novapharmanews.com/us/news/fda-update-diabetes-therapy-label-warning-2024 2026-07-01T01:24:56.643Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-genopharm-geno-cure-targeted-cancer-2024 2026-06-28T09:30:37.184Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-allerclear-otc-seasonal-allergies-2024 2026-07-01T15:58:57.766Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-bact-away-antibiotic-resistant-infections-2024 2026-06-30T23:48:29.766Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-algorithma-algo-1-trd-2024 2026-07-01T17:56:34.139Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-trial-update-semaglutide-obesity-2024 2026-07-01T10:34:35.908Z monthly 0.5 https://novapharmanews.com/apac/news/alamar-biosciences-nasdaq-ipo-precision-proteomics-debut 2026-07-01T19:57:50.620Z monthly 0.5 https://novapharmanews.com/apac/news/act-genomics-101-gene-panel-cancer-testing-upgrade-2026 2026-06-30T13:26:52.469Z monthly 0.5 https://novapharmanews.com/apac/news/qdenga-dengue-vaccine-approved-australia-tga-four-serotypes 2026-06-29T16:56:33.522Z monthly 0.5 https://novapharmanews.com/eu/news/ema-iris-psur-submission-requirements-september-2025 2026-06-30T12:01:53.321Z monthly 0.5 https://novapharmanews.com/us/news/revolution-medicines-zoldonrasib-phase-1-data-kras-g12d-lung-cancer-aacr-2026 2026-07-01T19:05:48.113Z monthly 0.5 https://novapharmanews.com/us/news/epibiologics-epi-326-phase-1-trial-egfr-cancer 2026-06-30T08:43:53.879Z monthly 0.5 https://novapharmanews.com/us/news/sbc-medical-group-secondary-offering-3-1-million-shares 2026-07-01T09:50:41.668Z monthly 0.5 https://novapharmanews.com/us/news/fda-terminates-gas-delivery-engine-ventilator-recall-16650a 2026-07-01T03:05:35.093Z monthly 0.5 https://novapharmanews.com/us/news/philip-morris-iqos-fda-reauthorization-modified-risk-tobacco-product 2026-07-01T16:08:51.707Z monthly 0.5 https://novapharmanews.com/us/news/ascentage-pharma-preclinical-cancer-studies-aacr-2026 2026-07-01T03:54:39.046Z monthly 0.5 https://novapharmanews.com/us/news/whitehawk-therapeutics-hwk-007-adc-data-aacr-2026 2026-07-01T17:59:19.820Z monthly 0.5 https://novapharmanews.com/us/news/pulnovo-medical-100-million-medtronic-investment-pulmonary-hypertension 2026-06-30T19:57:05.834Z monthly 0.5 https://novapharmanews.com/us/news/nuance-pharma-ohtuvayre-enhance-china-phase-3-copd-results-chest-journal 2026-06-29T15:02:14.232Z monthly 0.5 https://novapharmanews.com/us/news/lundbeck-vyepti-migraine-cognitive-symptoms-infuse-study-2026 2026-07-01T03:34:38.497Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-biosimilar-clone-remicade-2026 2026-07-01T14:16:02.090Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-arterioflow-pad-2024 2026-06-26T04:02:30.438Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-v-protect-vaccine-2026 2026-07-01T07:33:42.500Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-inno-med-inhaler-tech-asthma-2024 2026-06-30T03:31:27.734Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-duo-boost-type-2-diabetes-2024 2026-07-01T01:09:50.685Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-rgen-101-raregen-orphan-drug-2024 2026-07-01T12:44:58.186Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-inflammex-ulcerative-colitis-2026 2026-07-01T19:41:19.146Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-synapton-alzheimers-2026 2026-06-30T13:08:09.399Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-generic-epipen-mylan-2024 2026-06-30T23:30:41.741Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-prevnar-20-pediatric-indication-2024 2026-07-01T18:24:08.212Z monthly 0.5 https://novapharmanews.com/apac/news/zai-lab-zl-1503-bispecific-antibody-itch-relief-atopic-diseases 2026-07-01T20:17:50.958Z monthly 0.5 https://novapharmanews.com/apac/news/antengene-novel-cancer-programs-aacr-2026-adc-tce-therapies 2026-06-19T00:32:16.011Z monthly 0.5 https://novapharmanews.com/apac/news/antengene-adc-antengager-tce-programs-aacr-2026 2026-07-01T17:21:04.603Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-therapeutic-vaping-pharmacy-access-regulatory-framework 2026-07-01T18:44:07.143Z monthly 0.5 https://novapharmanews.com/apac/news/tga-medical-device-regulations-ai-software-therapeutic-products-australia 2026-07-01T16:10:27.170Z monthly 0.5 https://novapharmanews.com/eu/news/adagene-muzastotug-triple-combination-therapy-hepatocellular-carcinoma-aacr-2026 2026-07-01T04:16:10.009Z monthly 0.5 https://novapharmanews.com/eu/news/hytn-innovations-hard-cannabis-remediation-technology-gmp-processing-germany 2026-07-01T08:13:11.425Z monthly 0.5 https://novapharmanews.com/eu/news/sanofi-nuvaxovid-covid-vaccine-better-tolerability-mnexspike-phase-4-study 2026-07-01T18:45:11.250Z monthly 0.5 https://novapharmanews.com/eu/news/brand-institute-ema-approval-ai-pharmaceutical-branding-brandi-platform 2026-06-29T20:19:07.157Z monthly 0.5 https://novapharmanews.com/eu/news/ema-drug-patent-cliff-2026-european-exclusivities-expire 2026-07-01T09:58:49.792Z monthly 0.5 https://novapharmanews.com/eu/news/ema-chmp-recommends-six-new-medicines-approval-february-2024 2026-07-01T16:23:47.274Z monthly 0.5 https://novapharmanews.com/eu/news/ema-recommends-adstiladrin-gene-therapy-bladder-cancer-march-2026 2026-07-01T19:51:18.838Z monthly 0.5 https://novapharmanews.com/us/news/health-canada-approves-bracco-vueway-gadopiclenol-mri-contrast 2026-06-29T12:01:08.140Z monthly 0.5 https://novapharmanews.com/us/news/salubris-jk06-phase-1-2-cancer-trial-aacr-2024 2026-07-01T09:36:36.899Z monthly 0.5 https://novapharmanews.com/us/news/innate-pharma-iph5201-matisse-phase-2-aacr-2026-plenary-session 2026-07-01T16:23:42.102Z monthly 0.5 https://novapharmanews.com/us/news/accent-therapeutics-atx-295-kif18a-inhibitor-aacr-2026-cancer-data 2026-07-01T01:43:21.413Z monthly 0.5 https://novapharmanews.com/us/news/fda-reauthorizes-philip-morris-iqos-modified-risk-tobacco-product 2026-07-01T14:34:44.514Z monthly 0.5 https://novapharmanews.com/us/news/olema-oncology-palazestrant-op-3136-preclinical-data-aacr-2026 2026-07-01T19:35:26.162Z monthly 0.5 https://novapharmanews.com/us/news/ucb-acquires-neurona-therapeutics-nrtx-1001-epilepsy-cell-therapy 2026-06-30T17:31:53.421Z monthly 0.5 https://novapharmanews.com/us/news/xodus-medical-fda-clearance-hot-pink-pad-surgical-temperature-management 2026-07-01T14:28:41.834Z monthly 0.5 https://novapharmanews.com/us/news/argenx-vyvgart-myasthenia-gravis-cidp-aan-2026-clinical-data 2026-07-01T20:14:28.915Z monthly 0.5 https://novapharmanews.com/us/news/nuvalent-zidesamtinib-ros1-lung-cancer-aacr-2026 2026-06-29T20:00:11.890Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-verapamil-extended-release-hypertension-2024 2026-07-01T11:17:24.354Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-imgn-901-breakthrough-therapy-aml-2026 2026-07-01T08:49:15.772Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-revitan-gene-therapy-sma-type-3-2026 2026-07-01T00:26:59.440Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-mito-x-accelerated-approval-2024 2026-06-30T10:40:32.473Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-xylocor-refractory-angina-2026 2026-07-01T04:12:33.482Z monthly 0.5 https://novapharmanews.com/apac/news/atara-biotherapeutics-class-action-lawsuit-atra-stockholders-losses 2026-06-30T09:34:21.516Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approves-hanmi-hmpl-523-alzheimer-herbal-medicine 2026-06-29T17:17:44.434Z monthly 0.5 https://novapharmanews.com/eu/news/gene-therapy-market-growth-crispr-aav-technologies-2034 2026-06-30T19:15:42.826Z monthly 0.5 https://novapharmanews.com/eu/news/healthcare-cold-chain-logistics-market-growth-2034-biopharmaceuticals-asia-pacific 2026-06-30T20:14:01.721Z monthly 0.5 https://novapharmanews.com/eu/news/aim-immunotech-ampligen-phase-3-pancreatic-cancer-trial-orphan-drug 2026-06-30T09:43:03.927Z monthly 0.5 https://novapharmanews.com/eu/news/ab-science-masitinib-als-phase-3-trial-insurance-25-million 2026-07-01T10:52:36.743Z monthly 0.5 https://novapharmanews.com/eu/news/meiragTx-acquires-botaretigene-sparoparvovec-gene-therapy-xlrp-johnson-johnson 2026-07-01T06:15:37.473Z monthly 0.5 https://novapharmanews.com/eu/news/beamion-zongertinib-fda-approval-her2-mutant-nsclc-lung-1-study 2026-07-01T07:22:17.080Z monthly 0.5 https://novapharmanews.com/eu/news/tri-611-fda-fast-track-alk-positive-nsclc-eisai-taletrectinib 2026-07-01T04:38:33.544Z monthly 0.5 https://novapharmanews.com/us/news/maia-biotechnology-phase-2-nsclc-telomere-treatment-trial-us-site 2026-06-30T11:28:46.343Z monthly 0.5 https://novapharmanews.com/us/news/dr-falk-pharma-renexxion-naronapride-phase-2b-gastroparesis-ddw-2026 2026-07-01T10:00:03.729Z monthly 0.5 https://novapharmanews.com/us/news/lilly-foundayo-orforglipron-achieve-4-trial-results-mortality-reduction 2026-07-01T18:50:48.789Z monthly 0.5 https://novapharmanews.com/us/news/aicuris-pritelivir-fda-priority-review-herpes-treatment 2026-07-01T18:47:07.220Z monthly 0.5 https://novapharmanews.com/us/news/medera-aav-serca2a-fda-fast-track-duchenne-cardiomyopathy 2026-07-01T13:04:10.598Z monthly 0.5 https://novapharmanews.com/us/news/boehringer-ingelheim-zongertinib-her2-mutant-lung-cancer-nejm-study 2026-07-01T13:02:53.213Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-mindbalance-digital-therapeutic-2026 2026-07-01T20:17:35.836Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-cancervax-adjuvant-melanoma-2026 2026-06-29T17:30:29.384Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-painblock-patch-chronic-pain-2024 2026-06-30T00:27:05.059Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-renalprotect-expanded-use-dkd-2024 2026-07-01T13:54:16.455Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-lungrx-inhaled-therapy-pulmonary-hypertension-2026 2026-07-01T10:13:03.899Z monthly 0.5 https://novapharmanews.com/apac/news/sanyou-ai-stal-2-antibody-discovery-14-days-drug-development 2026-06-30T13:27:02.071Z monthly 0.5 https://novapharmanews.com/apac/news/gene-expression-analysis-market-593-billion-2031-drug-discovery 2026-06-18T23:39:27.018Z monthly 0.5 https://novapharmanews.com/apac/news/perceptive-discovery-mh3d-alpha-sight-radiopharmaceutical-imaging 2026-07-01T15:46:58.943Z monthly 0.5 https://novapharmanews.com/apac/news/pg-health-apac-pharmacist-guidelines-peripheral-neuropathy-management 2026-06-30T10:19:53.170Z monthly 0.5 https://novapharmanews.com/apac/news/tga-assessed-listed-medicines-framework-update-australia 2026-07-01T06:22:15.856Z monthly 0.5 https://novapharmanews.com/apac/news/corcept-therapeutics-relacorilant-fda-rejection-investor-lawsuit-2025 2026-07-01T15:59:14.880Z monthly 0.5 https://novapharmanews.com/apac/news/florida-cancer-specialists-medically-integrated-oncology-care-2024 2026-06-19T06:31:13.890Z monthly 0.5 https://novapharmanews.com/eu/news/traws-pharma-tivoxavir-marboxil-influenza-trial-ratutrelvir-covid-results-2025 2026-07-01T07:48:13.163Z monthly 0.5 https://novapharmanews.com/eu/news/tme-pharma-nox-a12-triple-therapy-brain-cancer-gloria-trial-nature-communications 2026-07-01T04:12:03.846Z monthly 0.5 https://novapharmanews.com/eu/news/additional-risk-minimization-measures-armms-training-course-patient-safety 2026-07-01T10:08:08.818Z monthly 0.5 https://novapharmanews.com/eu/news/healthcare-logistics-market-growth-159-billion-2030-biopharmaceutical-cold-chain 2026-06-30T00:40:48.915Z monthly 0.5 https://novapharmanews.com/eu/news/medical-device-software-compliance-training-eu-mdr-ivdr-fda-june-2026 2026-06-30T14:36:36.176Z monthly 0.5 https://novapharmanews.com/eu/news/onward-medical-40-million-capital-increase-eqt-life-sciences 2026-06-30T22:25:55.723Z monthly 0.5 https://novapharmanews.com/eu/news/sahpra-african-medicines-agency-regulatory-harmonization-course-may-2026 2026-07-01T14:51:38.358Z monthly 0.5 https://novapharmanews.com/eu/news/bavarian-nordic-vimkunya-chikungunya-vaccine-swiss-approval-swissmedic 2026-06-30T06:22:48.168Z monthly 0.5 https://novapharmanews.com/eu/news/seragon-srn-901-longevity-drug-lifespan-extension-preclinical-study 2026-07-01T16:10:22.211Z monthly 0.5 https://novapharmanews.com/us/news/fda-food-additive-contact-substance-regulatory-updates-2026 2026-07-01T08:00:07.604Z monthly 0.5 https://novapharmanews.com/us/news/recognition-health-alzheimers-blood-test-clinical-trial-2026 2026-07-01T15:46:50.386Z monthly 0.5 https://novapharmanews.com/us/news/sedogen-diazoxide-patent-prader-willi-syndrome-behavioral-symptoms 2026-06-29T23:25:48.663Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-lilrb4-cd3-bispecific-antibody-6mw5311-nmpa-ind-approval-leukemia 2026-07-01T08:04:42.194Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-maiweijian-denosumab-nmpa-acceptance-cancer-bone-treatment 2026-07-01T00:18:37.086Z monthly 0.5 https://novapharmanews.com/us/news/thinktrends-ai-federal-health-agency-adverse-event-monitoring-system 2026-07-01T19:31:21.271Z monthly 0.5 https://novapharmanews.com/us/news/fullscript-journeys-digital-health-platform-launch-2024 2026-07-01T15:39:13.895Z monthly 0.5 https://novapharmanews.com/us/news/nexalin-technology-fda-alzheimers-strategy-meetings-china-us 2026-07-01T07:37:38.858Z monthly 0.5 https://novapharmanews.com/us/news/fda-warning-letters-pharmaceutical-compliance-drug-safety-2024 2026-06-30T09:07:39.552Z monthly 0.5 https://novapharmanews.com/us/news/gsk-depemokimab-european-chinese-approval-ultra-long-acting-biologic 2026-06-29T06:42:29.715Z monthly 0.5 https://novapharmanews.com/us/news/elion-therapeutics-turletricin-phase-2-trial-invasive-mold-infections 2026-06-30T11:29:37.371Z monthly 0.5 https://novapharmanews.com/us/news/glaukos-epioxa-permanent-j-code-j2789-cms-approval 2026-07-01T15:32:02.276Z monthly 0.5 https://novapharmanews.com/us/news/nkarta-fda-approval-outpatient-nkx019-dosing-autoimmune-disease 2026-06-30T04:10:05.758Z monthly 0.5 https://novapharmanews.com/apac/news/phantom-neuro-phantom-x-first-human-trial-approval-australia 2026-06-30T21:40:04.938Z monthly 0.5 https://novapharmanews.com/eu/news/boehringer-ingelheim-zai-lab-dll3-targeting-combination-therapy-small-cell-lung-cancer-trial 2026-07-01T19:21:44.998Z monthly 0.5 https://novapharmanews.com/eu/news/imvt-1402-myasthenia-gravis-treatment-pipeline-2026 2026-07-01T19:45:09.090Z monthly 0.5 https://novapharmanews.com/us/news/dogwood-therapeutics-sp16-fda-ind-approval-chemotherapy-pain 2026-06-30T20:56:12.894Z monthly 0.5 https://novapharmanews.com/us/news/pds-biotech-pds01adc-78-percent-response-rate-colorectal-cancer-phase-2 2026-06-30T00:15:40.381Z monthly 0.5 https://novapharmanews.com/us/news/neffy-epinephrine-nasal-spray-approved-canada-needle-free-anaphylaxis-treatment 2026-06-30T23:30:23.150Z monthly 0.5 https://novapharmanews.com/us/news/cala-fda-clearance-kiq-plus-wearable-device-essential-tremor-parkinsons 2026-07-01T14:19:39.030Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-rapiblyk-landiolol-pediatric-svt-aop-health 2026-06-30T20:42:39.820Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-gi-innovation-gi-101a-phase-1-data-preview 2026-07-01T12:53:34.759Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-sleepwell-chronic-insomnia-2026 2026-07-01T16:49:28.477Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-nanopharm-metastatic-breast-cancer-2024 2026-06-30T20:22:49.970Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-fluguard-novel-influenza-vaccine-2026 2026-07-01T08:10:44.873Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cardiodetect-ai-diagnostic-arrhythmia-2026 2026-07-01T19:15:58.572Z monthly 0.5 https://novapharmanews.com/apac/news/phrontline-biopharma-tj106-her2-adc-preclinical-data-aacr-2026 2026-07-01T18:10:59.552Z monthly 0.5 https://novapharmanews.com/apac/news/xellsmart-xs411-parkinsons-cell-therapy-phase-ii-trial-2026 2026-06-30T19:19:33.194Z monthly 0.5 https://novapharmanews.com/apac/news/peer-ai-regulatory-platform-predictive-intelligence-life-sciences 2026-07-01T02:31:08.261Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-biologics-iso-13485-certification-drug-device-combination-products 2026-06-30T22:41:00.867Z monthly 0.5 https://novapharmanews.com/apac/news/atelerix-jh-health-partnership-cell-preservation-middle-east 2026-07-01T11:28:42.801Z monthly 0.5 https://novapharmanews.com/apac/news/chitosan-market-growth-kitozyme-primex-pharmaceutical-biopolymer-2036 2026-06-30T00:24:49.448Z monthly 0.5 https://novapharmanews.com/apac/news/telix-tlx101-tx-phase-3-glioblastoma-trial-first-patient 2026-07-01T13:21:25.352Z monthly 0.5 https://novapharmanews.com/apac/news/nmn-500mg-energy-support-tga-approval-australia 2026-06-30T23:07:49.337Z monthly 0.5 https://novapharmanews.com/eu/news/drug-development-services-market-31-billion-2026-pharma-rd-investments 2026-06-30T09:48:42.300Z monthly 0.5 https://novapharmanews.com/eu/news/medicenna-bizaxofusp-brain-cancer-trials-2026-investor-conference 2026-07-01T18:31:11.612Z monthly 0.5 https://novapharmanews.com/eu/news/vitestro-autonomous-robotic-phlebotomy-device-clinical-trial-results 2026-07-01T15:40:32.532Z monthly 0.5 https://novapharmanews.com/eu/news/grace-therapeutics-gtx-104-phase-3-strive-on-trial-aan-2026 2026-06-29T23:06:30.032Z monthly 0.5 https://novapharmanews.com/eu/news/mena-medical-device-regulatory-training-course-may-2026 2026-06-30T09:38:27.198Z monthly 0.5 https://novapharmanews.com/eu/news/cmo-cdmo-market-growth-biologics-manufacturing-2035 2026-07-01T10:58:04.368Z monthly 0.5 https://novapharmanews.com/eu/news/clinical-trial-monitoring-gcp-compliance-course-2026 2026-07-01T13:55:25.568Z monthly 0.5 https://novapharmanews.com/eu/news/gcp-inspections-training-course-ich-e6-r3-eu-ctr-compliance-july-2026 2026-07-01T00:52:53.331Z monthly 0.5 https://novapharmanews.com/eu/news/vabysmo-market-report-2026-roche-eye-drug-growth-forecast 2026-07-01T11:59:58.656Z monthly 0.5 https://novapharmanews.com/eu/news/glyconex-gnx1021-pmda-approval-phase-1-trial-gastrointestinal-cancers 2026-07-01T09:48:24.524Z monthly 0.5 https://novapharmanews.com/us/news/psoriasis-clinical-trial-pipeline-90-companies-2026 2026-07-01T12:09:29.500Z monthly 0.5 https://novapharmanews.com/us/news/meiragTx-aav-haqp1-gene-therapy-xerostomia-3-year-data-april-2026 2026-06-30T06:00:21.048Z monthly 0.5 https://novapharmanews.com/us/news/corbus-pharmaceuticals-crb-913-obesity-drug-canyon-1-trial-enrollment-complete 2026-07-01T02:29:18.523Z monthly 0.5 https://novapharmanews.com/us/news/actuate-therapeutics-elraglusib-pancreatic-cancer-survival-nature-medicine 2026-07-01T13:23:55.487Z monthly 0.5 https://novapharmanews.com/us/news/dupont-amberchrom-xt-sl-chromatography-resins-biopharmaceutical-manufacturing 2026-07-01T18:04:36.821Z monthly 0.5 https://novapharmanews.com/us/news/vasa-therapeutics-lilly-tunelab-ai-camkii-inhibitor-partnership 2026-06-30T22:42:29.924Z monthly 0.5 https://novapharmanews.com/us/news/synusight-biotech-sst001-alpha-synuclein-pet-tracer-nmpa-approval-phase-1-trial 2026-07-01T05:11:37.918Z monthly 0.5 https://novapharmanews.com/us/news/oryon-cell-therapies-appoints-burkhard-blank-chief-medical-officer 2026-06-30T12:06:08.677Z monthly 0.5 https://novapharmanews.com/us/news/amneal-launches-albuterol-beclomethasone-respiratory-inhalers-2026 2026-06-30T15:16:53.474Z monthly 0.5 https://novapharmanews.com/us/news/bright-path-fy2027-budget-domestic-pharmaceutical-manufacturing 2026-07-01T10:26:18.441Z monthly 0.5 https://novapharmanews.com/us/news/partner-therapeutics-bizengri-fda-application-cholangiocarcinoma-nrg1-fusion 2026-07-01T04:38:59.804Z monthly 0.5 https://novapharmanews.com/us/news/clearmind-medicine-cmnd-100-alcohol-use-disorder-trial-results 2026-07-01T00:17:22.659Z monthly 0.5 https://novapharmanews.com/us/news/praxis-precision-medicines-fda-accepts-ulixacaltamide-hcl-essential-tremor-nda 2026-07-01T08:59:00.936Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-filspari-sparsentan-fsgs-first-treatment-rare-kidney-disease 2026-07-01T10:43:34.711Z monthly 0.5 https://novapharmanews.com/us/news/apotex-fda-approval-generic-infuvite-adult-injection-exclusivity 2026-07-01T17:52:29.083Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-orphan-drug-rarecure-ert-2026 2026-07-01T11:00:31.299Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-migraease-new-migraine-drug-2024 2026-06-28T04:47:31.383Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-expanded-indication-elahere-2024 2026-07-01T19:18:43.538Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-cardioshield-hfpef-2026 2026-06-28T14:07:19.796Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-vitacorp-antibiotic-priority-review-2024 2026-07-01T11:54:46.328Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-neurovance-xr-pediatric-adhd-2026 2026-07-01T07:46:05.338Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-lumagen-gene-therapy-2024 2026-07-01T00:35:42.637Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-biosimilar-insulin-lispro-biosolve-2026 2026-07-01T07:02:47.713Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerated-approval-oncocure-trk-inhibitor-2024 2026-06-15T19:57:12.105Z monthly 0.5 https://novapharmanews.com/eu/news/ema-implement-ai-system-drug-safety-2024 2026-07-01T02:33:01.871Z monthly 0.5 https://novapharmanews.com/eu/news/european-commission-launches-blockchain-pilot-pharmaceutical-supply-chain-2024 2026-07-01T18:07:44.837Z monthly 0.5 https://novapharmanews.com/apac/news/nmepa-priority-review-ai-diagnostic-early-cancer-2024 2026-06-30T19:11:42.067Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-approval-ai-platform-personalized-medicine-oncology-2024 2026-07-01T02:59:56.645Z monthly 0.5 https://novapharmanews.com/us/news/fda-launches-blockchain-pilot-program-pharmaceutical-supply-chain-2024 2026-07-01T15:30:54.097Z monthly 0.5 https://novapharmanews.com/us/news/fda-implement-ai-powered-expedited-drug-review-2027 2026-07-01T17:29:50.361Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-renoprotect-diabetic-kidney-disease-therapy-2024 2026-06-16T09:53:45.099Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-airflow-inhalable-severe-asthma-2026 2026-07-01T19:03:20.428Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-osteobuild-bone-building-agent-severe-osteoporosis-2026 2026-07-01T17:50:10.275Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-arterioflow-peripheral-artery-disease-2026 2026-07-01T02:04:34.636Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-cholesterolrx-high-cholesterol-2024 2026-07-01T03:34:34.134Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-opti-sight-glaucoma-2026 2026-07-01T14:58:27.763Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-microbalance-crohns-disease-2026 2026-07-01T19:41:17.113Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-somnirestore-chronic-insomnia-2026 2026-07-01T19:22:49.542Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-neurobloc-non-opioid-pain-reliever-2026 2026-07-01T10:54:46.443Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-lysoclear-lysosomal-storage-disorders-2026 2026-07-01T11:01:51.411Z monthly 0.5 https://novapharmanews.com/eu/news/ema-conditional-approval-car-t-relapsed-b-cell-lymphoma-2024 2026-06-30T21:00:49.992Z monthly 0.5 https://novapharmanews.com/us/news/fda-breakthrough-therapy-targtex-tx202-glioblastoma-2024 2026-06-24T14:18:19.153Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-bria-cell-bria-imt-car-t-therapy-advanced-breast-cancer-2024 2026-07-01T05:07:57.225Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-zepzelca-lurbinectedin-cancer-treatment 2026-07-01T20:01:01.992Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-amgen-tarlatamab-imdylltra-small-cell-lung-cancer 2026-07-01T14:24:05.076Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-adstiladrin-gene-therapy-bladder-cancer 2026-07-01T19:51:18.813Z monthly 0.5 https://novapharmanews.com/eu/news/ema-recommends-imdylltra-tarlatamab-small-cell-lung-cancer-approval 2026-07-01T18:45:52.041Z monthly 0.5 https://novapharmanews.com/eu/news/ema-virtual-control-groups-reduce-animal-testing-drug-development 2026-07-01T18:34:27.820Z monthly 0.5 https://novapharmanews.com/us/news/fda-manufacturing-precheck-pilot-program-streamline-oversight 2026-07-01T15:04:39.875Z monthly 0.5 https://novapharmanews.com/us/news/real-world-evidence-transforms-drug-development-fda-regulatory-framework 2026-07-01T17:12:02.229Z monthly 0.5 https://novapharmanews.com/us/news/fda-untitled-letters-pharmaceutical-marketing-violations-database 2026-07-01T17:43:37.293Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-higher-dose-wegovy-7-2mg-weight-loss-priority-review 2026-07-01T15:51:37.516Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-avlayah-hunter-syndrome-neurologic-treatment 2026-06-30T17:15:03.921Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-kresladi-first-gene-therapy-lad-i-leukocyte-adhesion-deficiency 2026-06-30T18:34:16.033Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-foundayo-orforglipron-priority-voucher-program 2026-07-01T13:48:05.498Z monthly 0.5 https://novapharmanews.com/eu/news/ema-analysis-ai-pharma-rd-investment-2024 2026-07-01T08:11:18.419Z monthly 0.5 https://novapharmanews.com/eu/news/ema-accelerated-assessment-novel-mrna-vaccine-platforms-2024 2026-06-29T17:43:00.108Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approval-gene-therapies-neurological-disorders-2024 2026-07-01T09:48:57.797Z monthly 0.5 https://novapharmanews.com/eu/news/ema-clinical-trials-regulation-rare-disease-2026 2026-06-30T20:00:05.350Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-dermtech-skinguard-severe-eczema-2026 2026-06-22T15:06:40.537Z monthly 0.5 https://novapharmanews.com/eu/news/ema-blockchain-pharmaceutical-supply-chain-2024 2026-07-01T11:08:13.518Z monthly 0.5 https://novapharmanews.com/eu/news/ema-gdpr-impact-pharmaceutical-data-2024 2026-07-01T16:34:54.456Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-data-integrity-requirements-guide-2024 2026-06-30T19:06:15.014Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-cognimax-alzheimers-2026 2026-07-01T19:07:49.788Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-vitarestrore-age-related-macular-degeneration-2026 2026-07-01T14:32:08.470Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-nasoclear-pediatric-rsv-2026 2026-07-01T03:31:43.078Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-revitalize-chronic-fatigue-syndrome-2026 2026-07-01T15:34:42.498Z monthly 0.5 https://novapharmanews.com/eu/news/ema-ai-powered-clinical-trial-matching-patient-recruitment-2024 2026-07-01T03:22:40.607Z monthly 0.5 https://novapharmanews.com/eu/news/ema-regulatory-outlook-digital-therapeutics-europe-2024 2026-06-30T08:21:21.333Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-ai-clinical-trial-matching-china-2024 2026-06-30T14:45:06.412Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-telemedicine-apac-opportunities-challenges-2024 2026-07-01T05:32:34.029Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-genecorrect-gene-therapy-cystic-fibrosis-2026 2026-07-01T12:35:08.741Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-myorepair-breakthrough-therapy-2026 2026-06-30T06:42:40.171Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-oncoblock-refractory-aml-2024 2026-06-28T08:37:48.670Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-xylocor-nda-advanced-melanoma-2024 2026-06-25T14:02:56.677Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-repatha-evolocumab-cardiovascular-prevention-2024 2026-07-01T18:03:19.706Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-tecentriq-atezolizumab-es-sclc-2024 2026-07-01T14:40:59.553Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-opdivo-nivolumab-advanced-rcc-2024 2026-07-01T16:46:47.857Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-keytruda-adjuvant-stage-iii-melanoma-2024 2026-07-01T17:31:27.843Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-aduhelm-alzheimers-2021 2026-07-01T08:50:16.659Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-dupixent-eosinophilic-esophagitis-2024 2026-07-01T14:47:29.813Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-johnson-johnson-stelara-ulcerative-colitis-2024 2026-07-01T19:41:36.601Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-imfinzi-durvalumab-stage-iii-nsclc-2024 2026-07-01T08:37:17.194Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-trikafta-cystic-fibrosis-children-2024 2026-07-01T19:46:04.343Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-mounjaro-weight-management-2024 2026-06-30T04:05:17.855Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cosentyx-hidradenitis-suppurativa-2024 2026-07-01T19:32:49.746Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-moderna-mrna-1345-rsv-vaccine-2024 2026-06-30T22:32:00.921Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-zithromax-pediatric-cap-2026 2026-07-01T19:40:06.985Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-revivcor-etanercept-biosimilar-heart-failure-2024 2026-07-01T14:57:00.047Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-breakthrough-innovent-kras-g12c-inhibitor-2024 2026-07-01T07:57:17.192Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-accepts-shionogi-influenza-drug-sakigake-2024 2026-07-01T03:29:39.932Z monthly 0.5 https://novapharmanews.com/apac/news/cdsco-policy-changes-generics-market-growth-india-2024 2026-07-01T10:08:11.343Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-sakigake-designation-regenerative-medicine-market-access-2024 2026-07-01T15:48:29.412Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-priority-review-pathway-innovative-drug-approvals-2024 2026-07-01T14:18:25.698Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-inhalex-copd-2026 2026-07-01T03:31:43.055Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-rapiclot-tranexamic-acid-trauma-2026 2026-06-25T20:26:45.332Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-tarzenta-advanced-her2-negative-breast-cancer-2024 2026-06-19T11:04:59.569Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-ritempro-parkinsons-2026 2026-07-01T16:35:55.939Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-expedited-review-novel-melanoma-therapies-2024 2026-07-01T19:59:03.568Z monthly 0.5 https://novapharmanews.com/apac/news/tga-innovation-report-australian-biotech-solid-tumor-car-t-2024 2026-06-26T12:40:44.387Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-tevimbra-tislelizumab-escc-2024 2026-07-01T14:52:22.607Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-wainua-eplontersen-hattr-pn-2024 2026-07-01T19:51:29.281Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-sanofi-altuviiio-hemophilia-a-2024 2026-06-30T14:23:32.546Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-augtyro-repotrectinib-ros1-nsclc-2024 2026-07-01T12:50:56.548Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-litfulo-ritlecitinib-alopecia-2024 2026-07-01T16:22:33.687Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-gmp-standards-foreign-manufacturers-impact-2024 2026-07-01T16:20:17.049Z monthly 0.5 https://novapharmanews.com/eu/news/mhra-vs-ema-regulatory-pathway-strategy-2024 2026-07-01T12:41:46.072Z monthly 0.5 https://novapharmanews.com/eu/news/ema-market-analysis-orphan-drug-pricing-reimbursement-2024 2026-07-01T18:52:04.632Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-accelerated-approval-orphan-drugs-impact-future-trends-2024 2026-07-01T07:44:20.509Z monthly 0.5 https://novapharmanews.com/apac/news/ich-guidelines-biosimilar-development-apac-2024 2026-07-01T07:03:41.336Z monthly 0.5 https://novapharmanews.com/apac/news/cdsco-forecasting-biosimilar-market-growth-india-2024 2026-07-01T12:27:06.320Z monthly 0.5 https://novapharmanews.com/apac/news/tga-pmda-uptake-adalimumab-biosimilars-2024 2026-07-01T11:03:00.644Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-biosimilar-framework-trastuzumab-adoption-2024 2026-07-01T05:59:09.268Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-biosimilar-approval-pathway-analysis-2024 2026-07-01T17:31:52.380Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-repatha-pediatric-hefh-2024 2026-07-01T09:20:25.834Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-adzynma-thrombotic-thrombocytopenic-purpura-2024 2026-06-19T02:03:44.601Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-otc-naloxone-nasal-spray-opioid-overdose-2024 2026-07-01T00:43:30.898Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-sotorasib-kras-g12c-nsclc-2024 2026-07-01T04:21:27.440Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-veozah-fezolinetant-menopause-2024 2026-07-01T19:26:08.403Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-pmda-tga-pompe-disease-market-analysis-2024 2026-06-30T01:37:50.288Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-omidubicel-onlv-2026 2026-07-01T19:11:15.145Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-updated-covid19-vaccines-fall-2024 2026-07-01T11:07:23.160Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-bosulif-pediatric-cml-2024 2026-06-29T16:16:15.882Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-ztalmy-ganaxolone-cdkl5-deficiency-2024 2026-07-01T16:36:42.802Z monthly 0.5 https://novapharmanews.com/eu/news/ema-impact-eu-pharmaceutical-strategy-api-manufacturing-2024 2026-07-01T18:56:50.221Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-opdivo-nivolumab-gastric-cancer-2024 2026-07-01T20:21:33.748Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-breyanzi-car-t-mantle-cell-lymphoma-2024 2026-07-01T18:02:44.719Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerated-approval-mirvetuximab-soravtansine-elahere-2026 2026-07-01T18:58:23.078Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-elarek-osteoporosis-prevention-2026 2026-06-30T23:07:03.522Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-approval-bevacizumab-biosimilar-china-2024 2026-07-01T07:34:47.484Z monthly 0.5 https://novapharmanews.com/eu/news/ema-marketing-authorization-denosumab-biosimilar-2024 2026-07-01T06:59:58.384Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-interchangeable-biosimilar-ustekinumab-2024 2026-07-01T17:29:29.999Z monthly 0.5 https://novapharmanews.com/eu/news/chmp-positive-opinion-car-t-therapy-relapsed-b-cell-lymphoma-2024 2026-06-30T03:18:54.084Z monthly 0.5 https://novapharmanews.com/eu/news/ema-legislation-reform-biopharma-innovation-2024 2026-07-01T11:11:58.314Z monthly 0.5 https://novapharmanews.com/apac/news/tga-australia-early-phase-trials-analysis-2024 2026-07-01T16:23:50.465Z monthly 0.5 https://novapharmanews.com/eu/news/ema-artificial-intelligence-clinical-trials-guidelines-2024 2026-06-30T23:50:00.523Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-anti-inflammatory-atopic-dermatitis-2024 2026-07-01T14:44:50.725Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-amgen-bispecific-antibody-colorectal-cancer-2024 2026-07-01T07:59:41.838Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-syfovre-geographic-atrophy-2023 2026-07-01T15:18:24.458Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-endeavorrx-digital-therapeutic-adhd-2024 2026-07-01T15:56:30.278Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-roche-ntrk-fusion-therapy-2024 2026-07-01T13:26:22.130Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-casgevy-gene-therapy-sickle-cell-2023 2026-07-01T19:46:05.922Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-humira-biosimilar-interchangeable-2023 2026-07-01T16:41:22.261Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-gilead-hiv-bimonthly-treatment-2024 2026-06-28T02:27:58.811Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-astrazeneca-wilson-disease-2024 2026-07-01T04:07:18.120Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerated-approval-donanemab-alzheimers-2024 2026-06-30T18:55:54.283Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-novartis-breast-cancer-treatment-2024 2026-07-01T17:53:17.197Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-lumakras-nsclc-2023 2026-06-30T07:03:23.471Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-talquetamab-multiple-myeloma-2024 2026-07-01T15:49:04.887Z monthly 0.5